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ABSTRACT 
 
MULTI-COMPONENT CHARACTERIZATION OF STRAIN RATE  
SENSITIVITY IN PHARMACEUCTICAL MATERIALS 
 
 
 
By 
Jeffrey M. Katz 
December 2015 
 
Dissertation supervised by Ira S. Buckner, Ph.D. 
 Powder particles are brought into very close proximity by any number of 
sequential or concurrent consolidation mechanisms during tableting. It is commonly 
accepted that plastically deforming materials tend to be more strain rate sensitive than 
brittle materials, but this sensitivity depends on how fast the material can respond to 
applied stresses. In addition, since many pharmaceutical materials also demonstrate 
relatively large amounts of elastic deformation, it can be difficult to identify whether a 
material’s strain rate sensitivity is due to changes in elasticity or due to changes in 
plasticity at different speeds. 
 Compaction research is often performed on bench-top or small-scale presses that 
operate at press speeds orders of magnitude slower than production-scale machines. As a 
result, a variety of lab-scale methods have been developed to account for this difference. 
 v 
The most commonly utilized method is based on in-die Heckel analysis of 
compressibility data, but this approach does have limitations. Most notable is its inability 
to differentiate between the effects of changes to tablet press speed on elastic deformation 
from the effect on plastic deformation. A method that could identify the specific 
mechanical behavior, or behaviors, responsible for a material’s strain rate sensitivity 
would be significant. 
 In this dissertation, commonly used pharmaceutical excipients and simple 
mixtures were evaluated. Strain rate sensitivity was assessed using a multi-component 
approach. The scaled values of three lab-scale parameters: 1) Indentation Creep SRS 
Exponent,  2) ΔSFfinal, and 3) Heckel-Based SRS Index were used to describe material 
behavior. Using this combination of parameters, the sensitivity of the materials and 
mixtures can be quantified in terms of plasticity and elasticity, considered separately.  
 The combination of factors used in this study allows for a more detailed 
characterization of strain rate sensitivity. Factors that assess the time-dependency of both 
plasticity and elasticity offer the potential to understand what role each deformation 
behavior plays in the overall strain rate sensitivity of a material. This approach can 
facilitate rational product development and allow unexpected scale-up changes to be 
avoided.  
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Chapter 1: Introduction 
1.1 Statement of Problem 
 Pharmaceutical tablets are one of the most widely used and accepted forms of 
drug delivery [1]. A tablet has a number of advantages over other dosage forms including 
ease of handling, convenient administration and improved patient compliance [2]. Under 
optimum operating conditions some high-speed rotary tablet presses can produce over 
500,000 tablets per hour, making tablets one of the most cost effective dosage forms [3]. 
However, in early development studies the amount of drug substance that is available for 
testing is often limited to gram scale quantities. This eliminates the ability to utilize trial-
and-error methods for determining the behavior of materials and formulations between 
scales. As a result, the majority of tablet compaction research is performed on bench-top 
presses or small scale machines that operate at much slower compaction speeds. 
 Many problems that arise during the transfer of a tablet product from research to 
production scale are due to changing compression speeds. Tablet properties may change 
with respect to weight [4], tensile strength [5], friability [6], and disintegration time [7]. In 
addition, the consolidation properties (i.e. deformation behavior) of a material can be 
affected by the rate at which tablet compaction occurs. A material, whose deformation 
behavior is highly dependent on consolidation time and tablet press speed, is said to 
exhibit strain rate sensitivity (SRS).  
 Strain rate sensitivity is a significant problem facing formulation scientists and 
process engineers responsible for the successful development of drug products. 
Particularly sensitive materials may not possess the tablet strength necessary to withstand 
the rigors of downstream unit processes. They may also have an increased propensity for 
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capping and lamination upon ejection from the tablet die [8]. Post-manufacturing, 
finished products must be strong enough to remain intact following shipping, handling, 
and dispensing. A mechanically compromised tablet is unsuitable for use by a patient for 
many reasons including the loss of potency associated with a split or fragmented product.  
 Strain rate sensitivity can also significantly impact the financial resources allotted 
to the development team working on a pipeline compound. A tableted product that is 
mechanically weak or structurally damaged may incur considerable monetary costs 
related to re-formulation and/or significant process changes. Accurate characterization of 
the extent to which a material or formulation’s consolidation behavior will change, as a 
result of changes to tablet press speed, is necessary for the development of a quality drug 
product. 
 Characterization of strain rate sensitivity in pharmaceutical materials has widely 
relied on mean yield pressure determinations [9] derived from Heckel analysis [10,11]. 
This approach, although extensively used and recognized in compaction research, does 
have its limitations [12]. For example, the method using Heckel analysis does not 
differentiate between the effects of tablet press speed on elastic deformation from the 
effects on plastic deformation. Utilizing only in-die measurements to calculate mean 
yield pressure can lead to over prediction of strain rate sensitivity for materials that 
deform extensively during the unloading phase.  
 Other methods for predicting strain rate sensitivity have been reported and used to 
classify materials. Some examples include: deformation testing using diametral 
compression of cylindrical compacts [13], a novel non-destructive technique [14], 
numerical analysis of contact time and pressure data [15], and 3-D modeling [16]. 
 3 
Despite well-established considerations for the importance of characterizing strain rate 
sensitivity, the pharmaceutical literature is dominated by the work published by Roberts 
and Rowe.  
 In order to accurately evaluate changes to compaction behavior resulting from 
changes to tablet press speed, a more detailed characterization approach is required. A 
method that offers the potential to understand what contribution individual time-
dependent deformation behaviors play in the overall strain rate sensitivity of a material 
could be used to help avoid scale up issues like reduced consolidation leading to poor 
strength. A priori characterization of strain rate sensitivity is valuable for assessing the 
propensity of a material or formulation to behave differently at high speeds.  
 
1.2 Hypothesis and Objectives 
 This dissertation is based on the hypothesis that a multi-component, lab-scale 
assessment of strain rate sensitivity enables overall sensitivity to be quantified, and 
identification of the specific mechanical behaviors contributing to the observed 
sensitivity.  
 Given the central hypothesis, the objectives of this dissertation were to: 
1. Establish the effect of compression speed on the tableting profiles 
(compressibility and tabletability) of three common pharmaceutical excipients 
with varied deformation behavior.  
2. Introduce three lab-scale measurements that comprehensively describe the 
various aspects of strain rate sensitivity during powder compaction. 
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3. Quantify strain rate sensitivity using a multi-component parameter and 
identify the specific mechanical behaviors (i.e., viscoplasticity and 
viscoelasticity) that contribute to observed sensitivity. 
 The results of these objectives provide a blueprint for strain rate sensitivity 
characterization that offers the potential to understand what role individual deformation 
behaviors play in the overall sensitivity of materials and simple formulations. This 
dissertation provides a clear demonstration to the pharmaceutical industry that accurate 
characterization of strain rate sensitivity is possible using material-sparing, lab-scale 
techniques.   
 
1.3 Literature Survey 
1.3.1 Tablet Compaction and Deformation Behaviors 
 Despite its apparent simplicity, the conversion of a loose powder into a cohesive 
tablet is a complex process [17]. Initially, i.e. at low pressures, powder particles undergo 
sliding/rearrangement resulting in a closer packing structure and reduced powder bed 
porosity. At a certain pressure, the reduced pore space and increased inter-particulate 
friction will prevent any further inter-particle movement [18]. Subsequent volume 
reduction is, therefore, associated with changes in the dimensions of the particles.  
 The production of a tablet that is strong enough to withstand subsequent handling 
while allowing the active ingredient to be properly released upon administration is 
considered to be a function of the simultaneous processes occurring during its formation. 
In an effort to develop more robust products, a complete understanding of the 
fundamental behavior of new materials during tablet formation is required. 
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 From a material point of view, the description of compaction as a process that 
occurs in a sequence of consecutive, overlapping stages is considered the most common 
[19-21]. During compression, powder particles can deform either reversibly (elastic 
deformation) or irreversibly (plastic deformation and brittle fracture/fragmentation). If 
the applied pressure is less than the yield pressure, powder particles will deform 
elastically and regain their original shape upon decompression. In this range, stress is 
linearly proportional to strain and is characterized by Young’s (elastic) modulus [22]. 
Stored elastic strain is released as the powder particles within the compact expand 
eliminating bonding area developed during compression.  
 If the local pressure exceeds the yield pressure, powder particles begin to yield 
and deform plastically. A permanent change to the shape of the particle facilitates the 
formation of particle-particle contact regions during compression [23]. As the area at 
each contact point increases, local stress is relieved resulting in the increased formation 
of inter-particulate bonds. For brittle particles, fragmentation into smaller, discrete parts 
is generally preceded by little or no plastic deformation. Fracture stresses are most often 
controlled by the inherent flaws in the crystalline lattice that initiate failure [22]. As 
particles fragment, new surfaces are exposed leading to an increased number of inter-
particulate points of contact. Unlike plastic materials which improve tablet strength by 
increasing the contact area between particles, brittle materials exhibit less effective inter-
particulate bonding [24].   
 Although typical stress-strain behavior can provide information about the 
deformation characteristics of a material and the stresses required to induce such 
deformation, these data often represent ideal behavior which is rarely observed in 
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practice. In actuality, pharmaceutical powders almost always exhibit deformation by 
several different mechanisms with the relative contribution of each varying between 
materials. The deformation mode that will dominate depends on a number of factors 
including the pressure range of interest [25], intrinsic material properties [26], and the rate 
at which pressure is being applied [27]. As a result, characterization of specific 
deformation behaviors proves to be very challenging. 
 
1.3.1.1 Characterizing Deformation Behavior 
 Many methods exist to identify the predominant deformation mechanism of a 
material. The most common characterization approach is compressibility modeling. 
Compressibility is typically defined as the decrease in apparent volume due to an increase 
in the applied pressure [7]. The larger the decrease in apparent volume due to an applied 
pressure, the larger the material’s compressibility is. This property is not unique to 
powder compaction, but is one of the most fundamental mechanical properties used in 
tableting research. The most basic use is the generation of compressibility profiles, or 
functions of solid fraction versus applied pressure. Development scientists can use 
compressibility functions to determine the pressure required to produce a tablet with a 
given density or thickness. Furthermore, this profile can be very useful in evaluating 
other relevant tablet properties that are dependent on the level of consolidation.  
 Compressibility profiles have other, more profound uses. The relationship 
between applied pressure and solid fraction, or some transformation of solid fraction, has 
long been studied in an effort to provide insight into the fundamental mechanical 
behavior of powders during compaction. Various consolidation models have derived 
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parameters related to fundamental behaviors including apparent deformation mechanisms 
and the ability of the powder particles to rearrange into more dense configurations [28-
31]. When successful, these parameters provide an understanding of a material’s behavior 
that can be used to guide development decisions.  
 The most common model used to interpret solid fraction data is the Heckel model 
[10,11]. This model assumes compressibility to be a first-order process with respect to 
porosity of the powder bed. The Heckel equation is derived by solving the linear 
separable differential equation relating relative density (𝐷) and applied pressure (𝑃) 
according to Eq. (1). The step-by-step derivation is provided below: 
 
 
𝑑𝐷
𝑑𝑃
= 𝑘(1 − 𝐷) (1) 
 
Variables in Eq. (1) are separated to obtain Eq. (2): 
 
 
𝑑𝐷
(1−𝐷)
= 𝑘𝑑𝑃 (2) 
 
Eq. (2) is integrated across all applied pressures according to Eq. (3): 
 
 ∫
𝑑𝐷
(1−𝐷)
= 𝑘 ∫ 𝑑𝑃
𝑃
0
𝐷
𝐷0
 (3) 
 
The solved integral in Eq. (4) is rearranged to obtain Eq. (5): 
 
 ln(1 − 𝐷0) − ln(1 − 𝐷) = 𝑘𝑃 (4) 
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 ln (
1
1−𝐷
) = 𝑘𝑃 + ln (
1
1−𝐷0
) (5) 
 
The relative density associated with rearrangement, ln (
1
1−𝐷0
), is substituted for the 
variable, A, to obtain the Heckel equation provided in Eq. (6): 
 
 ln (
1
1−𝐷
) = 𝑘𝑃 + A (6) 
  
Solid fraction, or relative density, represents the fraction of the total volume that is made 
up by the solid particles. The remaining fraction, termed porosity (𝜀), is attributed to the 
pore space between particles and is calculated according to Eq. (7): 
 
 𝜀 = 1 − 𝐷 (7) 
 
Therefore, Eq. (6) can be rewritten with respect to porosity to match Eq. (8): 
 
 − ln(𝜀) = 𝑘𝑃 + 𝐴 (8) 
 
 The empirical parameter, 𝐴, reflects low pressure densification resulting from 
particle rearrangement. The slope, 𝑘, is related to the irreversible deformation mechanism 
and its inverse is known as the mean yield pressure (stress) or 𝑃𝑦 [32]. 𝑃𝑦 is widely 
accepted as an indicator of the relative plasticity of a material. 
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 Heckel analysis is most often implemented using one of two different approaches. 
The first measures powder bed dimensions during compression while the material is 
under load. This approach is referred to as the ‘at-pressure’ or ‘in-die’ method. 
Alternatively, tablet density can be assessed using the measurements of ejected tablet 
dimensions, and is often referred to as the ‘zero-pressure’ or ‘out-of-die’ approach. While 
both methods have advantages, both also suffer from weaknesses that limit their use. It 
was recognized by Heckel, and has been emphasized by several others since, that the 
porosity measured when the powder bed is under load can be significantly lower than the 
porosity that results after the load is removed [10,11,33-35]. The difference is attributed 
to the elastic recovery of the powder bed as the pressure is removed. Although out-of-die 
Heckel analysis is commonly accepted as more reliable than the in-die method, the out-
of-die approach involves compressing separate tablets at every pressure of interest. 
Considerably more material and time are required to perform out-of-die analysis 
compared to in-die, which can be completed during a single compression cycle.  
 Heckel’s original work was performed on metal and ceramic powders sieved to a 
particular particle size mesh with modified shape and surface texture [10,11]. He 
concluded that a materials behavior was plastic if a linear relationship between the 
negative natural logarithm of porosity and pressure existed, even if it occurred over a 
very limited pressure range. Conversely, Heckel identified a material as being 
predominantly brittle if no linear relationship could be identified. Applicability of this 
model to the compression of pharmaceutical materials requires careful attention, in part 
due to the original model being built on an entirely different class of materials.  
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 A Heckel profile is normally divided into three different regions. First, is a non-
linear section (Region I) occurring at low pressure. This is followed by a linear region 
(Region II) where the data obey Eq. (8). Finally, a second non-linear region (Region III) 
is observed at high pressure. A typical plot of − ln(𝜀) versus compaction pressure, 𝑃, is 
provided in Figure 1.  
 
 
Figure 1. Typical in-die Heckel Plot. Regions I and III represent behavior at low and high 
pressure, respectively. Region II is the linear region described by Heckel 
 
 For region I, Heckel attributed non-linearity to particle rearrangement processes 
in the absence of interparticulate bonding [10,11]. However, it should be noted that more 
recent investigations have also ascribed non-linear behavior at low pressure to rapid 
fragmentation of the powder particles [19].  
I II III
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 It is widely accepted that within region II particle deformation is the controlling 
mechanism. Although linearity in the Heckel plot is attributed to irreversible (plastic) 
deformation, it is also recognized that elastic deformation occurs at all pressures [34,35]. 
For region III it is recognized that elastic deformation of the compact controls the 
process, while non-linearity is a result of the mathematical treatment of the data. As the 
density of the powder bed under load approaches the true density, the negative natural 
logarithm of porosity approaches infinity. 
 
1.3.1.2 Tablet Compaction Equipment 
 Pharmaceutical tablets are usually produced by two types of tablet presses: single-
punch eccentric presses and rotary presses. A single-punch machine produces tablets by 
single-sided compaction. In this type of machine, the upper punch moves up and down 
above the stationary die. The die, and the lower punch remain in fixed positions during 
compression. After the tablet has been compressed, the lower punch is raised to eject the 
tablet through the upper opening of the die [36].   
 Rotary presses produce tablets using double-sided compaction. The complete 
tablet manufacturing cycle occurs in four steps: (i) die fill, (ii) mass adjustment, (iii) 
compression/decompression, and (iv) ejection (Figure 2, on the following page).  
 
 12 
 
Figure 2. Compaction cycle of a rotary tablet press. The stages of compaction 
(represented linearly) are labeled in order from left to right  
(Re-printed with permission from the publisher [3]) 
 
 For this type of machine, many punch and die sets are fitted around the periphery 
of a turret. The lower punch tip remains in the die at all times while the upper punch tip is 
removed from the die during tablet ejection and die fill. As the turret rotates, the punch 
heads are brought in turn between a pair of stationary rollers. Passing between the rollers, 
the upper and lower punch tips are moving toward each other and exert a compressive 
force on the powder bed between them [36]. 
 Compared to single-punch presses, rotary presses are capable of being operated at 
very high speeds. Almost all commercial tablet production is carried out on rotary 
machines. Single-punch presses are mostly used for development and formulation studies 
where only a small amount of active ingredient is available for use. Due to the intrinsic 
Die Fill 
Mass 
Adjustment 
Compression Ejection 
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differences between the two types of machines, they have drastically different punch 
speeds, force versus time profiles, and displacement versus time characteristics [37]. For 
these reasons, materials do not necessarily perform equally well on the two types of 
machines. Improved understanding of the changes in material behavior that can occur as 
a result of a change to tablet press speed is crucial for minimizing development costs.  
 In recent years, compaction simulators have become very popular due to their 
efficiency and ability to collect a large amount of data. Compaction simulators are 
assembled using three main units: a load frame, a hydraulic unit, and a data acquisition 
system [3]. Simulators are becoming more integrated into tablet development as they 
have become able to more accurately replicate the compression profiles of specific 
production-scale rotary tablet presses using small amounts of raw material. These 
machines are ideally suited to study the basic compaction behavior of materials, evaluate 
and optimize excipients such as lubricants and binders with respect to the desired tablet 
properties of the finished product, and provide information related to process and scale-
up variables like pre-compression and tablet press speed.  
 New machines are able to simulate production scale presses by implementing 
punch displacement profiles that account for the upper and lower pre and main 
compression rolls, applied force, dwell/contact times, and punch velocity. Unfortunately, 
factors like die fill, turret movement, and build-up of turret temperature due to long 
compaction runs at high speed remain hard to replicate using this type of equipment. 
Compaction simulators are highly valuable tools that should be used to streamline and 
improve tablet development studies. However, the mindset that these machines can be 
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used to practically eliminate the need for a thorough understanding of material behavior 
should be avoided. 
 
1.3.2 Strain Rate Sensitivity 
 Some pharmaceutical solids respond to stress differently when the stress is 
applied at different rates. Strain rate sensitivity arises as a result of a mismatch between 
the applied rate of stress and the rate at which the material being compacted can relieve 
those applied stresses. Problems can occur during scale-up operations when a formulation 
developed on a single-punch press is transferred to a high speed rotary tablet press.  
 From a material point of view, plastically deforming solids are often regarded as 
more sensitive to changes in the amount of time available for consolidation and bonding 
to occur due to the time-dependent nature of how those materials deform. Conversely, 
brittle materials are considered less sensitive to these changes since fragmentation of 
powder particles occurs rapidly. In addition to plastic deformation, the elastic response of 
materials to stress can also play a role in the material’s time-dependent behavior. Elastic 
recovery can occur immediately upon decompression or post-ejection over an extended 
period of time. This later behavior is attributed to time-dependent reversible deformation 
or viscoelasticity [38-40]. Since many pharmaceutical materials also demonstrate 
relatively large amounts of elastic deformation, it can be difficult to identify whether a 
material’s strain rate sensitivity is due to changes in elasticity or due to changes in 
plasticity at different speeds.  
 Time-dependent deformation behavior can manifest itself beyond simply 
identifying whether that behavior is sensitive to changes in tablet press speeds. As the 
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time scale for consolidation and bonding is shortened, quality problems such as reduced 
tablet strength as well as capping and lamination are encountered more frequently. 
Compromising the mechanical integrity of formed compacts can result in issues with 
downstream processing, or more importantly affect the dose required by a patient. 
Knowledge of the extent to which these changes can occur allows for improved 
formulation development in an effort to mitigate scale-up issues related to properties of 
the final product.   
 
1.3.2.1 Effect of Strain Rate on Consolidation and Recovery 
  Tablet dimensions are a combined result of the extent of consolidation and the 
amount of relaxation that occurs post ejection. It is often observed that powders 
compacted on a research scale tablet press form tablets of adequate strength and quality. 
However, as the time allowed for consolidation is decreased, material behavior can 
change significantly. For example, the apparent density of two tablets compressed to the 
same pressure can be significantly different depending on the speed at which they were 
compressed. The amount by which apparent density changes will depend on the primary 
consolidation mechanism that material displays [13].  
 Tye et al. [41] examined the tableting behavior of four commonly used excipients 
having varied deformation behaviors. The out-of-die compressibility profiles of two sets 
of tablets were compared. The first was compressed on a hydraulic press used to emulate 
slow speed compaction conditions. The second was generated using a compaction 
simulator which represented high speed, or manufacturing scale press settings. Of the 
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four materials, pre-gelatinized starch showed the greatest decrease in solid fraction with 
speed (Figure 3). 
 
 
Figure 3. Compressiblity profiles of pre-gelatinized starch compacted using four different 
dwell times: (ӿ) 8 ms, (■) 27 ms, (♦) 20 s, and (▲) 90 s  
(Re-printed with permission from the publisher [41]) 
 
 Longer dwell times (i.e. slower press speeds) resulted in tablets with a higher 
measured solid fraction, or lower porosity, across all applied pressures. It is commonly 
accepted that plastically deforming materials tend to be more sensitive to press speed 
than brittle materials, but this sensitivity depends on how fast the material can respond to 
applied stress. Under prolonged compression time, pre-gelatinized starch particles can 
more effectively flow into inherent void spaces increasing inter-particulate contact area 
and lowering measured porosity.  
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 The effect of tablet press speed on the extent of consolidation has also been 
assessed by comparing the maximum applied force needed to produce tablets of 
equivalent solid fraction [42,43]. Armstrong and Palfrey [44] examined the effect of 
tablet press speed on the compressibility or four commonly used tableting diluents. A 
modified hand-operated eccentric press was operated at speeds ranging from 0.33 to 2.67 
rev/s corresponding to production rates of 20 and 160 tablets/min, respectively. An 
inorganic brittle material (dicalcium phosphate) showed little change in the force required 
to produce tablets of equal solid fraction. Deformation of this material occurs by 
fragmentation of the original particles into smaller, distinct units that subsequently pack 
together. Fragmenting materials can more efficiently react to changes in the rate of force 
application since consolidation proceeds quickly.  
 Conversely, for the plastic materials, an increase in the rotational speed of the 
press accompanied an increase in the maximum detected force. If the rate at which a load 
is applied exceeds the rate at which a material can react to that load, an increased 
resistance to further densification will occur. As a result, the force required to produce a 
tablet of equivalent solid fraction increases with speed. Due to the nature by which they 
deform, plastic solids are considered to exhibit greater strain rate sensitivity as compared 
to solids that primarily fragment during the formation of a tablet. However, strain rate 
sensitivity is not only a function of the mode by which a material permanently deforms. 
The relaxation behavior of materials has also been shown to be sensitive to the speed at 
which a material is compressed [38-40, 45-47].  
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 Tablet relaxation is often quantified as an increase in volume, or tablet thickness 
and diameter, after ejection from the die [48-51]. Volume change is regularly calculated 
according to Eq. (9): 
 
 ∆𝑉 =
𝑉∞−𝑉𝑚𝑖𝑛
𝑉𝑚𝑖𝑛
 (9) 
 
where 𝑉∞ is the tablet volume at various time points after ejection and 𝑉𝑚𝑖𝑛 is the 
minimal tablet volume during compression. By using minimum tablet volume for the 
calculation of changes to the total volume, relaxation measurements can be used to 
evaluate both the elastic and viscoelastic recovery of the tested material. The extent to 
which a tablet expands over time can have significant implications on finished product 
quality. Not only must a tablet be able to survive the mechanical stresses encountered 
during downstream unit operations, but damaged products will fail to provide the efficacy 
expected by the patient.  
 Maarschalk et al. [52,53] examined the effect of tableting speed on the relaxation 
behavior of pre-gelatinized starch whose behavior is predominantly plastic and/or 
viscoelastic. Tablets were prepared on a compaction simulator under speeds ranging from 
3 to 300 mm/s. Tablet dimensions were accurately measured with a micrometer after 
ejection from the die and over time until the dimensions were no longer changing. Proper 
corrections for punch elasticity were made, which is important for the precise calculation 
of in-die thickness used to determine 𝑉𝑚𝑖𝑛.  
 It was evident that the elastic and viscoelastic behavior of starch depended on the 
speed used to compress each tablet. Higher porosities were measured for tablets that were 
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compressed at faster speeds. The authors observed that an increase in tablet volume with 
speed was a result of the competition occurring between permanent deformation and 
elastic recovery of the tablet. At slow speeds, permanent deformation controlled 
consolidation while the elastic component was relatively insignificant. The amount of 
reversible stored energy was low, which coincided with the smallest observed volume 
changes during relaxation. Conversely, at high speed, the elastic component controlled 
consolidation as less time was available for permanent deformation to occur. After 
compression, residual elastic strain was recovered causing a larger increase in tablet 
volume relative to the same tablet compacted at slower speed.  
   
1.3.2.2 Effect of Strain Rate on Tablet Properties 
 Powder particles are brought into sufficiently close proximity by any number of 
sequential or concurring consolidation mechanisms. Some of which have been shown to 
contribute to a materials strain rate sensitivity. To form a coherent compact, bonding 
must occur between those particles. During research and development where limitations 
on testing are controlled by the amount of raw material available, tablets prepared at slow 
speeds exhibit adequate strength. The tablet presses used to form these tablets are 
operated at orders of magnitude slower speeds than the machines that would be used to 
produce similar tablets at the manufacturing scale. Early investigators [54,55] found that 
the crushing strength of tablets was reduced when the rate of tablet production was 
increased. Several other important studies have been performed over the years related to 
the issues of strain rate and tensile strength [5, 56-58]. 
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 In a diametral compression test, stress is applied to tablets across their diameter 
between two flat platens [59-61]. Tablet failure along the diameter, across which the load 
is applied, allows tensile stress (𝜎) causing failure to be calculated using Eq. (10): 
 
 𝜎 =
2𝑃
𝜋𝐷𝑡
 (10) 
 
where 𝑃 is the breaking load, and 𝐷 and 𝑡 are the diameter and thickness of the tablet 
specimen. Tensile strength is widely used as an indicator of mechanical strength since its 
value reflects the amount of bonding that has occurred during compression [62-64]. 
 Cook and Summers [65] studied the speed sensitivity of binary mixtures 
containing aspirin. Although the primary goal was to assess mixture behavior, the data 
collected on each individual component illustrated the effect of speed on resultant tablet 
strength. Tablets compacted on a slow speed mechanical press were compared to tablets 
compacted at higher speed on a Manesty E2 machine. The punch velocity on the rotary 
machine (5500 – 7500 mm/min) was significantly greater than the crosshead speed used 
to control punch velocity on the mechanical press (1 mm/min).  
 Tensile strength was plotted as a function of mixture composition for each of the 
materials tested. Individual component data was analyzed by comparing the data point 
values plotted on the x-axis at 0 and 100 % composition. Those x-axis compositions 
corresponded to aspirin and all of the other individual components that were tested, 
respectively. Emcompress®, a calcium phosphate inorganic binder, formed tablets that 
showed a minimal difference in measured tensile strength between speeds. By contrast, 
Starch 1500® exhibited a significant reduction in tensile strength as the press speed used 
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to compact each tablet increased. An increase in porosity was experienced as a result of 
decreased inter-particulate contact area formed during compression at high speeds. It was 
hypothesized that less particle-particle contact reduced the effective area over which 
bonds between particles were formed. The tablet strength of a brittle material was 
minimally affected by changes to press speed, whereas the plastic material being tested 
was affected to a much greater extent. 
 In another study, Marshall et al. [5] studied the effect of punch velocity on the 
compaction properties of ibuprofen, a material often characterized as consolidating via a 
balance between elastic and plastic deformation [66,67]. The authors compressed tablets 
from a recrystallized 1-90 μm size fraction of ibuprofen using a compaction simulator. A 
series of applied loads were used to compress the material and minimally three replicate 
compacts were produced at each load. Tensile strength was determined 2 hours after 
ejection using diametral compression testing. It was concluded that ibuprofen exhibited 
strength behavior characteristic of a strain rate sensitive material, that is, a reduction in 
strength was observed with an increase in compression speed. More importantly, this 
study highlights an important caveat to tensile strength testing methods that has 
significant implications on the accurate measurement of those values. 
 The rate at which load is applied to tablet specimens during diametral 
compression testing can affect measured values. Rees et al. [68] compared tablet strength 
values of compacts prepared with microcrystalline cellulose and lactose. Two different 
loading rates, corresponding to platen speeds of 0.05 and 5 cm/min, were tested. An 
increase in the loading rate produced a significant increase in the breaking strength of 
both materials. A change to the loading rate during testing has also been shown to cause a 
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decrease in measured tensile strength [69]. For that reason, efforts have been made to 
establish methods ensuring similar strain rate conditions during testing [70]. 
 It was proposed by Hiestand et al. [70] to control cross head (platen) speed such 
that the time between failure load and the failure load divided by e (the base of natural 
logarithms) should be approximately 5 s. By using a time constant, instead of a pre-
determined rate of testing, tensile strength values are considered to more correctly reflect 
the relative bond strengths of materials. As a result, more meaningful comparisons of 
changes to tensile strength with speed can be made between materials with different 
strain rate sensitivities. Although the lack of sufficient tablet mechanical strength is the 
most common problem encountered during tablet manufacturing, poor mechanical 
performance in the form of tablet defects can make tablets produced at high speed 
unsuitable for use. 
 Capping and lamination are problems which frequently occur during tablet 
production. Capping is defined as the separation of the top curvature of a tablet from the 
tablet body either partially or completely during ejection, subsequent handling or physical 
testing [8]. Lamination, on the other hand, involves the failure of a tablet along planes 
perpendicular to the applied compression stress causing the splitting apart of a tablet [71]. 
While the therapeutic efficacy of drug products is crucial for proper treatment, tablets of 
sufficient mechanical strength must also be able to survive handling, packaging, shipping, 
and storage prior to reaching the patient. Although capping and lamination aren’t the only 
mechanical defects affecting finished product integrity (i.e. picking, sticking, etc.), they 
remain the most commonly observed during manufacturing.  
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 Reported root causes of tablet capping and lamination in the literature include: 
non-uniform tablet density distributions [72], anisotropic mechanical properties [73], air 
entrapment [74], and die wall pressure leading to internal shear stresses in the tablet [75]. 
The predominant deformation mode of a material can also have a direct effect on the 
physical and mechanical properties of the final product. Malamataris et al. [76] suggested 
that capping and lamination frequency depended on the elastic and plastic behavior of the 
material being studied. The authors observed that strain rate sensitive materials 
experience increased capping and lamination propensity upon ejection, which they 
attributed to the relative contribution of both permanent and reversible deformation 
changing with speed [76]. 
 In another study, Garr and Rubenstein [77] examined the effect of compression 
speed in the range of 24 – 850 mm/s on the capping tendency of parcetamol. Capping or 
lamination tendency was determined by close visual examination of tablets upon ejection, 
with visual horizontal striations representing lamination. The intensity of capping 
increased with an increase in compression speed. This behavior was attributed to changes 
in the extent of plastic and elastic deformation with speed. A 65 % increase in elastic 
energy was observed between compression speeds of 24 and 850 mm/s when compacted 
to a consistent maximum load of 20 kN. By comparison, only a 33 % increase in plastic 
energy was observed over the same speed range. Based on this study, along with others 
[78,79], it can be concluded that at increased speeds, the powder bed responds by 
preferentially deforming elastically over permanent plastic deformation. Consequently, 
elastic strain recovered during ejection causes the formulation particles to separate, 
leading to a greater tendency for either capping or lamination. In other words, faster 
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compression speeds lead to weaker inter-particulate bonding and more elastic recovery, 
which both favor capping and lamination. 
 
1.3.2.3 Characterization of Strain Rate Sensitivity 
 Strain rate sensitivity is most frequently characterized using the difference in 
mean yield pressure values obtained by compacting a material at two different speeds [9]. 
More specifically, a strain rate sensitivity index (Eq. (11)) was developed based on the 
percentage increase in mean yield pressure determined from in-die Heckel plots between 
punch velocities of 0.033 mm/s (𝑃𝑦1) and 300 mm/s (𝑃𝑦2): 
 
 𝑆𝑅𝑆 =
𝑃𝑦2−𝑃𝑦1
𝑃𝑦2
× 100 (11) 
 
 A high speed compaction simulator, able to operate over a wide range of punch 
velocities, was used to simulate both research and production scale tablet press speeds. A 
summary of the materials tested by Roberts and Rowe is provided in Table 1 on the 
following page. 
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Table 1. Heckel-Based SRS Index values for a wide range of materials 
(Re-printed with permission from the publisher [9]) 
Material SRS % 
 
Calcium phosphate -- 
Calcium carbonate -- 
Heavy magnesium carbonate -- 
Paracetamol D.C. 1.8 
Paracetamol drug 10.6 
Lactose 16.2 
Tablettose 19.2 
Anhydrous lactose 20.3 
Avicel PH 101 38.9 
Sodium chloride 38.9 
Mannitol 46.4 
Maize starch 49.3 
Corvic 
 
54.1 
 
 
 Materials were ranked in terms of their brittle and ductile behaviors. For materials 
known to deform plastically (e.g. maize starch) there was an increase in the yield pressure 
with punch velocity. The authors attributed this increase to be a result of a reduction in 
the amount of plastic deformation or a transition from ductile to brittle behavior [9]. For 
materials known to consolidate by brittle fragmentation (e.g. calcium carbonate) there 
was a minimal change in mean yield pressure with increasing punch velocity.  
 This index was developed for material comparison and as a tool to improve 
understanding of the effects of strain rate on deformation. This approach, although 
extensively used and recognized in compaction research, has its limitations. First of all, 
Heckel analysis itself is an empirical model whose application can frequently provide 
inconsistent or misleading results. For example, the method using in-die Heckel analysis 
does not differentiate the effect of strain rate on elastic deformation from the effects on 
plastic deformation. Fundamentally, mean yield pressure determinations are derived from 
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in-die compaction which allows elastic deformation to confound the results. Under load, 
the measured porosity decreases as the particles elastically deform. As the load is 
removed and the tablet is ejected from the die, the porosity increases as the elastic 
deformation is reversed. This recovery causes in-die analysis to under predict mean yield 
pressure. Consequently, the strain rate sensitivity determined from in-die data will reflect 
changes in elasticity as well as changes in plasticity. 
 Secondly, in order to effectively assess strain rate effects using this method, a 
fairly dramatic compaction speed difference is needed due to the uncertainty of mean 
yield pressure values. The relationships between mean yield pressure and punch velocity 
presented in the original study did not indicate that the mean yield pressure at 300 mm/s 
was of intrinsic value, but was simply the fastest speed studied. These punch velocities 
are not always achievable on standard testing equipment making consistent application of 
this method difficult. Although the strain rate sensitivity derived from in-die Heckel data 
remains the most wildly used approach for characterizing materials, other methods for 
evaluating strain rate sensitivity have been reported. Of particular interest to this work are 
methods that can characterize the strain rate sensitivity of individual deformation modes. 
Understanding strain rate sensitivity specifically related to plastic flow should provide an 
opportunity to develop a more complete understanding of the influence of tablet speed on 
different materials while complementing standard characterization methods.  
 Stress relaxation measurements have been used to characterize plastic flow of 
pharmaceutical materials during compaction. Typically, a material is compressed to a 
pre-defined peak force at which point the position of the upper and lower punches are 
held fixed. This fixed position estimates virtually constant strain; a requirement for stress 
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relaxation testing. As the compressed material relaxes, force-decay is monitored and 
recorded as a function of time. Several examples of stress relaxation experiments exist in 
the literature [13, 80-83], a few of which report the dependence of force-decay on the 
deformation behavior of the material being studied.  
 David and Augsburger [84] investigated the behavior of various materials using 
an instrumented rotary tablet press. The effects of the duration of the compression cycle 
and the duration of maximum compressive force (dwell time) were studied. The authors 
found that increasing the duration of maximum compressive force resulted in an increase 
in measured tensile strength for all materials tested. For known plastic materials (i.e. 
microcrystalline cellulose and starch) a much greater increase was observed. The authors 
hypothesized that the observed tensile strength increase was due to an increase in the 
extent of plastic flow with time.  
 To test this hypothesis, force-decay profiles collected at constant strain were 
modeled using a simplified Maxwell model used to describe viscoelastic behavior [7, 85]. 
A logarithmic relationship was derived using constitutive equations representing a 
Hookean elastic spring and a Newtonian viscous dashpot in series. The simplified 
relationship is provided in Eq. (12): 
 
 𝑙𝑛∆𝐹 = 𝑙𝑛∆𝐹0 − 𝑘𝑡 (12) 
 
where ∆𝐹 is compression force remaining in the viscoelastic region at time (𝑡) and ∆𝐹0 is 
the total magnitude of the compression force at time (𝑡 = 0). Compression force decay 
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was modeled as a first order rate process where its rate constant, 𝑘, represents the 
viscoelastic slope (Table 2). 
 
Table 2. Viscoelastic slope (𝑘) and total compression force lost 
 (Re-printed with permission from the publisher [84]) 
Material Viscoelastic Slope (𝑘) 
Total Compression Force Lost 
in Viscoelastic Region (kg) 
 
Compressible starch 
 
0.336 
 
63 
Microcrystalline cellulose 0.332 53 
Compressible sugar 0.281 37 
Dicalcium phosphate 
 
0.182 
 
7 
 
 
 Larger 𝑘 values are attributed to increased plastic deformation during dwell time 
hold periods. Plastic material particles are able to flow into void spaces; increasing 
particle-particle contact and relieving local stress. For brittle materials, the total 
compression force lost was minimal, and much less than the force lost for starch and 
microcrystalline cellulose. Newly developed points of contact, created from particle 
fracture and associated rearrangement, allows for quick equilibration of the applied stress 
throughout the powder bed. 
 Despite its use for assessing time-dependent plasticity, stress relaxation tests can 
be hard to perform. In particular, properly maintaining constant strain conditions has been 
identified as being problematic. Slight changes to punch position can cause measureable 
force changes that can be misinterpreted as being caused by changes in tablet dimensions 
[13,86]. In order to take advantage of the value of testing materials whose properties 
depend on the rate and duration of loading, a complimentary technique that utilizes 
constant stress experimental conditions can be used. Indentation creep experiments 
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typically involve pushing an indenter into a formed tablet at a pre-determined loading 
rate and then holding the load on the indenter constant while the displacement of the 
indenter is monitored as a function of time. Strain rate sensitivity measurements using 
indentation hardness are routine for metallic and ceramic materials [87-91]. Indentation 
hardness (𝐻) is calculated at each time point during the hold region according to 
previously established methods [92, 93] using Eq. (13): 
 
 𝐻(𝑡) =  
𝐹
𝐴
 (13) 
 
where 𝐹 is the applied force and 𝐴 is the contact area between the indenter and the 
compact at a specific time (𝑡). Indentation strain rate (𝜀?́?) [94-98] is defined as the ratio 
between the depth of penetration (ℎ) at a specific time (𝑡) and the corresponding 
instantaneous rate of penetration (
𝑑ℎ
𝑑𝑡
) using Eq. (14):  
 
 𝜀?́?(𝑡) =
1
ℎ
×
𝑑ℎ
𝑑𝑡
 (14) 
 
 A plot of ln hardness vs. ln strain rate yields a linear relationship, whose slope 𝑚, 
indicates the change in hardness with respect to changes in strain rate as shown in Eq. 
(15): 
 
 𝑚 =
𝜕[𝑙𝑛𝐻(𝑡)]
𝜕[𝑙𝑛?̇?𝐻(𝑡)]
 (15) 
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Materials are compared and assessed for their sensitivity to strain rate by comparing how 
the penetration of the indenter changes as a function of the displacement rate. It has been 
shown that indentation creep data can be used to compare the viscoplasticity of 
particulate materials [99,100]. Since the creep method is based on data collected after 
elastic deformation is finished, its results should be directly related to time-dependent 
plasticity.  
 Using a trial-and-error approach to tablet development is frequently identified as 
being too time consuming and too costly. As a result, lab-scale strain rate sensitivity 
characterization methods that are capable of predicting the extent to which an actual 
formulation’s behavior will change upon scale-up are important for the successful 
development of tableted drug products. Traditional techniques, although still used in 
practice, have limitations that complicate interpretation of the data. Other approaches 
provide information that is not influenced by competing deformation processes. In cases 
where a detailed understanding of a material’s strain rate sensitivity is called for, 
alternative evaluation approaches, in combination with traditional methods, should 
provide more specific results that allow the identification of the specific mechanical 
behaviors that are responsible for observed strain rate sensitivity. 
 
1.4 Summary 
 Changes to tablet compression speed can cause considerable changes to material 
behavior. During development, often relatively small tablet presses are used which 
operate at slow speeds. Although restrictions on raw material usually exist, simulation of 
large scale production conditions is difficult using machines that operate at speeds orders 
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of magnitude slower than those utilized during manufacturing. Understanding to what 
extent changes in deformation behavior can occur, as the rates of compression and the 
time over which force is applied to the powder changes, is crucial for the reliable 
development of tableted products. In efforts to improve development efficiency, powder 
materials are frequently characterized at lab-scale where much less material is needed for 
testing. Assessment of time-dependent deformation behavior should facilitate 
identification of active pharmaceutical ingredients, excipients, and formulations which 
may be difficult to tablet on high speed rotary tablet machines. 
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Chapter 2: Effect of Compression Speed on the Tableting Profiles of 
Three Common Pharmaceutical Excipients 
 
 It is important to establish the effects of compression speed on product quality 
attributes such as tablet solid fraction and tablet tensile strength. In this chapter, 
compressibility and tabletability profiles were generated and used to assess the effects of 
strain rate during tableting. Compressibility (solid fraction vs. compaction pressure) and 
tabletability (tablet tensile strength vs. compaction pressure) relationships provide 
valuable information about a material’s tendency to behave differently at different 
compression speeds.  
 A Huxley-Bertram compaction simulator was used to study the compaction 
properties of three commonly used pharmaceutical excipients at high speed. (Note: due to 
time constraints on the compaction simulator, only a subset of the materials studied in 
this dissertation was compacted using this equipment). Tablets for each of the three 
materials were prepared in the materials science laboratory at the Pfizer research facility 
in Groton, CT. Subsequent analysis was performed in-house at Duquesne University.  
  
2.1 Experimental 
2.1.1 Materials 
 The pharmaceutical diluents used in this chapter were chosen based on their 
varied deformation behavior. A base formulation containing an internally blended binder 
(Copovidone, 3 %), glidant (Colloidal silicon dioxide, 0.5 %), and lubricant (Magnesium 
stearate, 0.5 %) was used for all experiments. Raw material supplier information, 
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functionality, and % w/w composition for the three diluents and the base formulation 
components are provided in Table 3. 
  
Table 3. Raw material supplier information, functionality, and composition (% w/w) 
Material (Trade name) 
Supplier 
(Location) 
Functionality % w/w 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
 
Roquette 
(Keokuk, IA) 
 
 
Diluent 
 
 
96.0 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
FMC Corporation 
(Philadelphia, PA) 
 
 
Diluent 
 
 
96.0 
 
Dibasic calcium 
phosphate dihydrate 
(Emcompress®) 
 
JRS Pharma 
(Germany) 
 
 
 
 
Diluent 
 
 
 
96.0 
Copovidone 
 
ISP Technologies 
(Wayne, NJ) 
 
 
Binder 
 
3.0 
Colloidal silicon dioxide 
 
Evonik Industries 
(Parsippany, NJ) 
 
 
Glidant 
 
0.5 
 
Magnesium stearate 
 
Spectrum 
(Gardena, CA) 
 
 
Lubricant 
 
0.5 
 
 The diluents listed in Table 3 (Lycatab® PGS, Avicel® PH200 and Emcompress®) 
comprised the remaining 96 % w/w in each formulation. Throughout this dissertation, for 
simplicity, formulations will be referred to as either ‘individual components’ or 
‘mixtures’. If the formulation contained only one diluent, then it will be referred to as an 
‘individual component’ by the name of that material. If the formulation contained two 
diluents in combination, those will be listed as ‘mixtures’ and will be referred to by 
providing the % w/w of each diluent in the formulation.   
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 In an attempt to limit the variability resulting from disparities in physical 
properties on the compaction behavior of these materials, all experimentation was carried 
out using powders with equivalent particle size ranges (180 - 250 μm), which were 
equilibrated at ambient temperature (~ 23 – 25 ˚C) in a controlled relative humidity 
environment (saturated MgCl2, ~ 32 – 33 % relative humidity [101]).  
 
2.1.2 Data Collection 
2.1.2.1 Raw Material Characterization 
 Each material was characterized for its true density, moisture content, and particle 
size distribution. True densities were determined by helium pycnometry (Model: SPY-
6DC, Quantachrome Instruments, Boynton Beach, FL) and performed in triplicate for 
each excipient. Inherent moisture content was quantified using loss on drying 
measurements (Computrac Max 2000 Moisture Analyzer, Arizona Instruments, Phoenix 
AZ) of accurately weighed powders. Samples (1.5 – 2.0 g) were heated to 105 ˚C and 
held isothermally until the rate of moisture loss was less than 0.1 %/min. Sieve analysis 
(Performer III Model: SS-3, Gilson Company, Lewis Center, OH) was used to determine 
the particle size distributions of 50 g of powder. Collected fractions ( >1000, 1000-500, 
500-250, 250-180, 180-125, 125-75, 75-53, and <53 μm) were weighed at intervals 
ranging from 5 to 15 min until the measured weight change was less than 0.1 g.  
 
2.1.2.2 Tablet Compaction 
 A Huxley-Bertram servohydraulic compaction simulator (Model HB1088) was 
used to compact Lycatab® PGS, Avicel® PH 200, and Emcompress® formulations. The 
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simulator used in this work is a sophisticated tool that enables compaction at very high 
speeds. Automated operation allows for a large amount of tablets to be compacted in a 
short period of time. The die-table contains multiple hoppers that can be used to deliver 
powder to the die, and a take-off arm that mechanically slides an ejected tablet towards 
the carousel. A 3D rendering of the working area of the Huxley-Bertram simulator is 
provided in Figure 4. Significant machine parts are labeled.  
 
 
Figure 4. Huxley-Bertram compaction simulator. 3D view of working area with 
significant machine parts labeled  
(Re-printed from equipment documentation provided by manufacturer) 
 
 In this work, powder was gravity fed during die-filling, and the carousel was used 
to separately collect replicate tablets. Machine instrumentation specifications were 
extracted from the maintenance manual. For the upper and lower load cells the maximum 
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error in the transducer was reported to be ± 0.5 %. The encoder responsible for recording 
punch position values also has a reported maximum error of ± 0.5 %.  
 Each compact was prepared by weighing 500 mg of powder into a 13-mm 
stainless steel, cylindrical die with standard B punch tooling. Each material was 
compacted at three different compaction speeds (4, 40, and 400 mm/s) using a 50 kN load 
cell. The same speed was used for both compression and decompression, and no dwell 
time was included at the minimum punch separation distance. Compaction pressure, 𝑃, 
was determined by dividing the applied load (recorded at each minimum punch 
separation distance), or force, by the projected area over which that force was distributed. 
Eq. (16) was used to determine the applied pressure, in MPa, for all tablets:   
 
 𝑃 =
𝐹𝑜𝑟𝑐𝑒
𝜋𝑟2
 (16) 
 
where the radius, 𝑟, was 6.5 mm for all tablets. Varied minimum punch separation 
distances were used to compact tablets across a range of out-of-die solid fraction. 
 
2.1.2.3 Out-of-Die Solid Fraction 
 After ejection, tablets were stored for 7 – 10 days depending on how long it took 
for measured dimensions to no longer change. The dimensions of each tablet were 
measured using a digital caliper (Mitutoyo, Japan). The weight (𝑚), out-of-die thickness 
(𝑡), out-of-die diameter (𝑑), and powder true density (𝜌𝑡𝑟𝑢𝑒) of each tablet were used to 
obtain the out-of-die solid fraction according to Eq. (17):  
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 𝑆𝐹 =
4𝑚
𝜋𝑑2𝑡𝜌𝑡𝑟𝑢𝑒
 (17) 
 
 Reported out-of-die solid fraction values represent the average and standard 
deviation of 3 replicate compacts at each minimum punch separation distance. 
 
2.1.2.4 Radial Tensile Strength 
 The radial tensile strength of each tablet compressed on the Huxley-Bertram 
simulator was measured using an Instron universal material testing system (Model 5869, 
Instron Corporation, Norwood, MA) outfitted with a 1 kN load cell. Tablets were 
compressed across their diameter between two rectangular metal gauges, the width of 
which was less than one-sixth of the tablet diameter (2.0 mm). The metal gauges were 
covered with two strips of blotting paper to minimize the effect of shear and compressive 
stresses at the points of contact with the tablets. Specific cross-head speeds were also 
utilized in order to ensure similar strain rate conditions during testing (Section 1.3.2.2). 
The rate of testing used for each material is provided in Table 4.  
 
Table 4. Radial tensile strength upper platen speeds 
Individual Component 
Rate of Testing  
(mm/min) 
 
Lycatab® PGS 
 
5.0  
 
Avicel® PH 200 
 
4.2 
 
Emcompress® 
 
1.1 
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 Tablet failure along the diameter in which the load was applied allows the tensile 
stress causing failure to be calculated according to Eq. (10). Reported radial tensile 
strength values represent the average and standard deviation of 3 replicate compacts at 
each minimum punch separation distance.  
 
2.1.2.5 Tablet Relaxation 
 Punch separation distance at the maximum applied compressive load was used to 
obtain minimum in-die tablet thickness. The punch displacement data was corrected for 
deformation of the machine parts. An example of how this correction was performed is 
provided. The difference between the corrected and recorded punch separation distance 
for Emcompress® compressed at 4 mm/s is shown in Figure 5.  
 
 
Figure 5. Recorded (―) and corrected (―) punch separation profiles for Emcompress® 
compacted at 4 mm/s 
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 At low pressure, or force, the difference between the recorded and corrected data 
is minimal. However, as the applied pressure increases a progressively larger difference 
was observed. The difference in the recorded and corrected punch separation distance at 
max pressure was equal to 0.42 mm for this example. Failure to correct for the 
deformation of the machine parts can lead to a significant differences in in-die tablet 
thickness, and as a result, the minimum tablet volume (𝑉𝑚𝑖𝑛).  
 To correct the in-die punch separation distance, the displacement measured during 
compression of the punches in an empty die was added to the punch separation measured 
during the formation of each compact. Both the loading and unloading force-
displacement data for compression of the punches in an empty die were fit to a 6th order 
polynomial to account for any hysteresis in the complete loading/unloading profile. 
Punch deformation corrections were performed using empty die data collected at the 
same speed used to compact each tablet. For example, profiles for the loading and 
unloading segments of an empty die compressed at 4 mm/s are shown in Figures 6 and 7, 
respectively.  
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Figure 6. Empty-die loading profile collected at 4 mm/s 
 
Figure 7. Empty-die unloading profile collected at 4 mm/s 
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 Corrected punch separation distance was used to determine the in-die thickness 
(ℎ𝑖𝑛) of the powder bed. In-die tablet dimensions were used to calculate the in-die tablet 
volume (𝑉𝑜𝑙𝑢𝑚𝑒 (𝐼𝑛 − 𝐷𝑖𝑒)) according to Eq. (18):  
 
 𝑉𝑜𝑙𝑢𝑚𝑒 (𝐼𝑛 − 𝐷𝑖𝑒) = 𝜋(6.5𝑚𝑚)2ℎ𝑖𝑛 (18) 
 
where the radius of the tablet die was 6.5 mm. Following ejection from the die and 
viscoelastic relaxation of each tablet, the out-of-die tablet thickness (ℎ𝑜𝑢𝑡) and tablet 
diameter were also measured. Out-of-die tablet dimensions were used to calculate the 
out-of-die tablet volume (𝑉𝑜𝑙𝑢𝑚𝑒 (𝑂𝑢𝑡 − 𝑜𝑓 − 𝐷𝑖𝑒)) according to Eq. (19):  
 
 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑂𝑢𝑡 − 𝑜𝑓 − 𝐷𝑖𝑒) = 𝜋𝑟𝑜𝑢𝑡
2ℎ𝑜𝑢𝑡 (19) 
 
where the radius of the ejected tablets (𝑟𝑜𝑢𝑡) was half of the measured diameter. Volume 
change was calculated according to Eq. (9), presented in Chapter 1 Section 1.3.2.1. Large 
volume change values indicate larger changes in tablet dimensions in both the axial and 
radial directions relative to the dimensions of the tablet confined to the die. Reported 
tablet relaxation values represent the average and standard deviation of 3 replicate 
compacts at each minimum punch separation distance. 
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2.2 Results and Discussion 
2.2.1 Raw Material Characterization 
 Summarized data for powder true density and moisture content of Lycatab® PGS, 
Avicel® PH 200, and Emcompress® formulations is provided in Table 5 below. 
 
Table 5. True density and moisture content values of formulations 
Formulation’s Primary Ingredient True density % Moisturea (S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 1.458 (0.004) 8.408 (0.066) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
1.550 (0.004) 
 
5.672 (0.040) 
 
Dibasic calcium phosphate dihydrate 
(Emcompress®) 
 
2.301 (0.002) 
 
3.130 (0.058) 
 
a Loss on drying 
 
 The reported true density values were calculated from the true density of the 
individual materials according to the true density and weight fraction of each component 
in the formulation.  
 Particle size distributions, reported as percent undersize, for the same three 
materials are provided in Table 6, on the following page.  
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 Table 6. Particle size distribution of each diluent determined by sieve analysis 
 Percentage undersize 
Material 
<53 
μm 
<75 
μm 
<125 
μm 
<180 
μm 
<250 
μm 
<500 
μm 
<1000 
μm 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 22.8 22.8 27.7 49.8 77.8 95.0 99.9 
 
Microcrystalline cellulose 
(Avicel® PH 200) 7.2 7.2 8.9 18.5 32.7 60.3 100.0 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
1.0 
 
1.0 
 
2.4 
 
14.3 
 
29.8 
 
84.9 
 
98.1 
 
  
 The 180 – 250 μm sieve fraction was selected for use based on the particle size 
distribution of Lycatab® PGS, alone. Selection of this size fraction was warranted given 
the presence of Lycatab® PGS in each mixture for the studies presented in Chapter 4. The 
mass percentage in this range was 28.0 % and was the most abundant sieve fraction for 
this material. Since this material was used most frequently, collecting the 180 – 250 μm 
sieve fraction would maximize powder usage in both the lab-scale and compaction 
simulator experiments.    
 
2.2.2 Compaction Properties 
 The compressibility profiles for each of the three materials studied are shown in 
Figure 8, on the following page. The figure legend identifies the data point marker type 
used for each corresponding material.  
 44 
 
Figure 8. Huxley-Bertram simulator compressibility profiles for Avicel® PH200 (Δ), 
Lycatab® PGS (◊), and Emcompress® (□) compacted at 4 mm/s. Data points represent 
average values (n = 3) and associated error bars represent standard deviation 
 
 The rate of change in solid fraction as a function of applied compaction pressure 
gives an indication of powder compressibility. For the data presented in Figure 8, it was 
evident that Avicel® PH200 and Lycatab® PGS were more compressible than 
Emcompress®. That is, the change in solid fraction over a similar pressure range was 
greater for those two materials than it was for Emcompress®. Quantitatively, the change 
in solid fraction across the entire pressure range for Emcompress® was ~ 0.16, whereas 
for Lycatab® PGS and Avicel® PH200 the change in solid fraction was approximately 
0.28 and 0.24, respectively. The larger changes in solid fraction for Lycatab® PGS and 
Avicel® PH200 were expected based on previously reported data for these materials [102, 
103]. Similarly, the poor compressibility of Emcompress® has also been reported 
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previously, and was considered to be a function of the deformation tendency of that 
material during the formation of a tablet [104]. 
  The tabletability of each material was also assessed. Tabletability is the ability of 
a powder bed to transform into a coherent compact as a result of an applied compaction 
pressure [7]. Tabletability is represented by a profile of radial tensile strength plotted 
against compaction pressure. The tabletability profiles for each of the three materials are 
shown in Figure 9.  
 
 
Figure 9. Huxley-Bertram simulator tabletability profiles for Avicel® PH200 (Δ), 
Lycatab® PGS (◊), and Emcompress® (□) compacted at 4 mm/s. Data points represent 
average values (n = 3) and associated error bars represent standard deviation 
 
 The tabletability data for Avicel® PH200 demonstrates high values of tablet 
tensile strength at all compaction pressures. This can be attributed to the high 
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compressibility of this material, as discussed previously. Plastic deformation in this 
material results in the formation of extensive inter-particle contact area, which results in 
high tablet tensile strength [105]. The material with the lowest tabletability was 
Emcompress®. Since this material was poorly compressible (Figure 8) relative to the two 
other materials studied, it was not unexpected to observe such results. Reduced 
compressibility leads to fewer points of inter-particle contact formed during compaction.  
 For Lycatab® PGS, the tabletability data shows consistently low tablet tensile 
strength values when compared to Avicel® PH200. This is in contrast to the high 
compressibility shown by this material. For starch based products, it is often reported 
that, although they compress efficiently, they show extensive elastic recovery during 
decompression and large amounts of viscoelastic recovery post-ejection [41]. In this 
work, similar behavior was observed. Tablet relaxation data for each material is plotted 
as a function of compaction pressure in Figure 10, on the following page. 
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Figure 10. Huxley-Bertram simulator tablet relaxation profiles for Lycatab® PGS (◊), 
Avicel® PH200 (Δ), and Emcompress® (□) compacted at 4 mm/s. Data points represent 
average values (n = 3) and associated error bars represent standard deviation 
 
 Clearly, Lycatab® PGS exhibited the greatest amount of tablet relaxation across 
all pressures. Much smaller changes in tablet dimensions were observed for Avicel® 
PH200 and Emcompress®. Deformation plays a very important role in the formation of 
inter-particle contact area. Irreversible deformation mechanisms such as brittle fracture 
and plastic deformation help in the formation of contact area between particles. On the 
other hand, excessive elastic relaxation of tablets during decompression and/or large 
amounts of viscoelastic recovery, can lead to destruction of the inter-particle contact area 
formed during compression resulting in a lower measured tensile strength (Figure 9).  
 Meaningful comparisons can be made between materials using the tableting-
related profiles presented in Figures 8-10. Information related to consolidation and tablet 
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relaxation behavior is easily ascertained. However, these data were collected at a 
compaction speed (4 mm/s) that is much slower than the speeds that would be used to 
prepare tablets at the manufacturing scale. Depending on the material, powder particles 
may deform differently at different speeds. This can cause variations in the extent of 
consolidation, the amount of tablet relaxation behavior, and as a result the measured 
tablet tensile strength. The following section will be used to identify strain rate sensitivity 
in the common tableting-related profiles presented in this section. For clarity, strain rate 
sensitivity data has been grouped by material. 
 
2.2.3 Effect of Tablet Press Speed on Compaction Properties 
2.2.3.1 Emcompress® 
 The effect of compression speed on the compressibility profile of Emcompress® is 
shown in Figure 11, on the following page. The figure legend indicates the linear 
compaction speed used to form each tablet.  
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Figure 11. Huxley-Bertram simulator compressibility profiles for Emcompress® 
compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s 
(Δ). Data points represent average values (n = 3) and associated error bars represent 
standard deviation 
 
 For Emcompress® there was no effect of compression speed on the 
compressibility of this material. Equivalent functions of out-of-die solid fraction versus 
pressure were achieved regardless of the speed used to form each tablet. All curves were 
overlaid and indistinguishable from one another. The tabletability profiles, tablet tensile 
strength versus compaction pressure, compacted at the same three speeds were also 
collected and are plotted in Figure 12.  
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Figure 12. Huxley-Bertram simulator tabletability profiles for Emcompress® compacted 
at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s (Δ). Data 
points represent average values (n = 3) and associated error bars represent standard 
deviation 
 
 A higher compaction pressure resulted in a stronger tablet at all speeds. It was 
also evident that the linear compaction speed did not have a significant effect on tensile 
strength when compared at equivalent compaction pressure values. For example, tablets 
compacted to a maximum pressure of 150 MPa showed tensile strength values of ~ 1.5 
MPa, regardless of speed. For the tablets compressed at 400 mm/s there is a slight 
reduction in the radial tensile strength above 150 MPa relative to the strength of the 
tablets compacted at 4 and 40 mm/s. An increase in tablet relaxation behavior appears to 
be responsible for this change. The volume change versus pressure profile for 
Emcompress® is provided in Figure 13.   
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Figure 13. Huxley-Bertram simulator tablet relaxation versus pressure profiles for 
Emcompress® compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), 
and 400 mm/s (Δ). Data points represent average values (n = 3) and associated error bars 
represent standard deviation 
 
 Above 150 MPa, a larger volume change was observed for tablets compacted at 
400 mm/s compared to the recovery of the tablets compacted at 4 and 40 mm/s. Higher 
elastic relaxation during decompression and higher viscoelastic relaxation over time leads 
to reversing inter-particulate bonding area developed during compression and reduced 
tablet tensile strength. Although the reduction in tensile strength in this situation is 
negligible, it remains important to identify the source of these changes.  
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2.2.3.2 Avicel® PH 200 
 The effect of compression speed on the compressibility profile of Avicel PH 200® 
is shown in Figure 14. As before, the figure legend represents the linear compaction 
speed used to form each tablet.  
 
 
Figure 14. Huxley-Bertram simulator compressibility profiles for Avicel® PH 200 
compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s 
(Δ). Data points represent average values (n = 3) and associated error bars represent 
standard deviation 
 
 Avicel® PH 200 showed sensitivity to compression speed in its compressibility 
profile. At all levels of applied pressure, lower values of solid fraction were obtained for 
tablets that were compacted at higher speed. In other words, as the amount of time 
available for consolidation to occur decreased (i.e., an increase in compaction speed), the 
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extent of consolidation decreased. The tabletabilty behavior of Avicel® PH200 was also 
investigated at the same three compaction speeds. Those profiles are plotted in Figure 15. 
  
 
Figure 15. Huxley-Bertram simulator tabletability profiles for Avicel® PH 200 compacted 
at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s (Δ). Data 
points represent average values (n = 3) and associated error bars represent standard 
deviation 
 
 A reduction in tablet tensile strength corresponding to a progressive increase in 
the rate of compaction was observed. Weaker tablets were produced at faster speed. 
Previously, it was shown for Emcompress®, that similar behavior was attributed to an 
increase in the tablet relaxation behavior, albeit to a much lesser extent. So, in an attempt 
to identify the source of the observed reduction in tablet tensile strength with speed for 
Avicel® PH200, the volume change versus pressure profiles were plotted in Figure 16.    
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Figure 16. Huxley-Bertram simulator tablet relaxation versus pressure profiles for 
Avicel® PH 200 compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s 
(□), and 400 mm/s (Δ). Data points represent average values (n = 3) and associated error 
bars represent standard deviation 
 
 The amount of elastic and viscoelastic recovery that occurs is not significantly 
dependent on the speed used to prepare each tablet. The curves are indistinguishable from 
one another confirming that the amount of recovery observed is practically equivalent. 
Since the tablet recovery data was not affected by the same speed changes, the reduction 
in strength in the tabletability profile can be attributed to the lower out-of-die solid 
fraction (i.e., compressibility) of those tablets when compared at the same maximum 
pressure. Tablets with a lower solid fraction have reduced areas of inter-particulate 
contact area resulting in a reduction in the overall network of bonded interactions.  
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2.2.3.3 Lycatab® PGS 
 The effect of compression speed on the compressibility profile of Lycatab® PGS 
is shown in Figure 17. The figure legend represents the linear compaction speed used to 
prepare each tablet. 
 
Figure 17. Huxley-Bertram simulator compressibility profiles for Lycatab® PGS 
compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s 
(Δ). Data points represent average values (n = 3) and associated error bars represent 
standard deviation 
 
 The compressibility of Lycatab® PGS is susceptible to changes in the rate of 
compaction. Large reductions in solid fraction were observed as the tablet press speed 
was incrementally increased from 4 to 400 mm/s. For example, at a compaction pressure 
of ~ 85 MPa, the measured solid fraction at 4 mm/s was 0.68 whereas at 400 mm/s the 
solid fraction was reduced to a value of 0.60. Tablet tensile strength versus pressure data 
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was also compared as a function of speed. The tabletability profiles for Lycatab® PGS are 
provided in Figure 18. 
  
 
Figure 18. Huxley-Bertram simulator tabletability profiles for Lycatab® PGS compacted 
at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), and 400 mm/s (Δ). Data 
points represent average values (n = 3) and associated error bars represent standard 
deviation 
 
 The tensile strength of Lycatab® PGS compacts is significantly affected by 
compaction speed. At the same compaction pressure, the tablet strength decreases as the 
speed used to prepare each compact increases. These results are not unexpected and 
compare favorably to similar results presented for starch based excipients in the literature 
[9,44,84,106]. The source of the sensitivity in the tabletability profile appears to be due to 
a reduction in solid fraction with speed (Figure 17). However, it could also be due to 
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changes in the tablet relaxation behavior. The reversible response of Lycatab® PGS to 
speed is presented in Figure 19. 
   
 
Figure 19. Huxley-Bertram simulator tablet relaxation versus pressure profiles for 
Lycatab® PGS compacted at three different compaction speeds: 4 mm/s (◊), 40 mm/s (□), 
and 400 mm/s (Δ). Data points represent average values (n = 3) and associated error bars 
represent standard deviation 
 
 Unlike Emcompress® and Avicel® PH 200, the reversible behavior of Lycatab® 
PGS depends on the speed used to compact each tablet. For the tablets compressed at 400 
mm/s, a larger tablet volume change was observed when compared to the tablets 
compacted at both 4 and 40 mm/s. At higher speed, larger amounts of elastic strain are 
recovered. This causes a larger increase in tablet volume at higher speed relative to the 
volume change at slower speed. Since both the tablet recovery data and the 
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compressibility data were affected by the same speed changes, the reduction in strength 
in the tabletability profile appears to be due to a combination of both properties. As a 
result, the extent of bond formation that remains in the ejected tablets is reduced, as are 
measured tensile strengths. 
 
2.3 Summary 
 The effect of tablet press speed changes on the compressiblity, tabletability, and 
tablet relaxation properties of three common excipients were studied using a compaction 
simulator. The sensitivity of each profile is categorized and listed in Table 7. 
.  
Table 7. Summary of effect of compression speed on compaction properties 
Individual Component Compressibility  Tabletability Tablet Relaxation  
 
Pre-gelatinized maize 
starch (Lycatab® PGS) Sensitive Sensitive Sensitive 
 
Microcrystalline cellulose 
(Avicel® PH 200) Sensitive Sensitive Insensitive 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
Insensitive 
 
Insensitive 
 
Insensitive 
 
 
 Practically speaking, insensitivity in these compaction profiles suggests that the 
compaction behavior of this material is not significantly affected by changes in tablet 
press speed. For example, in the tablet relaxation profile for Emcompress®, the measured 
volume change at slow speed (i.e., lab-scale conditions) should be nearly equivalent to 
the measured volume change at high speed (i.e., manufacturing scale conditions). Where 
it becomes significantly more complicated is when one of these profiles exhibits 
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sensitivity. Sensitivity, by itself, would indicate that nearly equivalent compaction 
properties would not be expected as tablet press speed changes. In the case of Avicel® 
PH200, sensitivity in the tabletability profile was attributed to sensitivity in the 
compressibility data. In other words, a reduction in tablet tensile strength with speed was 
due to a reduction in solid fraction at those same speeds. For Lycatab® PGS, sensitivity in 
the tabletability profile was due to a combined effect of sensitivity in the compressibility 
and tablet relaxation data.  
 Sensitivity, or lack thereof, in these profiles is often explained for these materials 
in terms of their deformation behavior because they are materials that are well-known 
and have been studied frequently. However, these profiles cannot always be used to 
provide a direct connection to the deformation behavior that is responsible for observed 
strain rate sensitivity. Certainly it can be argued that sensitivity in the tablet relaxation 
profiles is due to viscoelasticity, but changes in solid fraction at different rates (i.e., 
compressibility) can be due to viscoelastic behavior as well as due to time-dependent 
plastic flow. Accordingly, a strain rate sensitivity characterization method that could 
differentiate between the sensitivity of viscoplasticity and viscoelasticity would be of 
significance.  
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Chapter 3: Lab-Scale Measurements that Comprehensively Describe 
the Various Aspects of Strain Rate Sensitivity During Powder 
Compaction 
 
 
 There exists a need to characterize a material’s time-dependent deformation 
behavior in addition to evaluating strain rate sensitivity in compressibility and 
tabletability profiles. Identifying the specific mechanical behavior, or behaviors, that are 
responsible for observed strain rate sensitivity would be of great significance during 
formulation development studies. Time-dependent processes are involved throughout the 
entire cycle of tablet compaction including the loading, dwell time, and unloading phases 
[86,107, 108]. When stress is applied to a powder to form a tablet, the mechanical 
properties of the resulting tablet are a function of the deformation tendencies of that 
material. The extent of irreversible particle deformation depends on the amount of time 
stress is applied during loading. Conversely, during decompression and post-ejection 
from the die, the release of residual elastic strain disrupts the initially formed inter-
particle contact area. The relative amounts of reversible and irreversible deformations are 
time-dependent.  
 Table 8, on the following page, summarizes each of the three parameters used to 
evaluate the various aspects of strain rate sensitivity in this work. Selection of the 
parameters listed in Table 8 was based on the theoretical connection between each one, 
and the mechanical behaviors related to strain rate sensitivity. The equations used to 
determine each measurement are provided. 
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Table 8. Lab-scale parameters used to characterize strain rate sensitivity 
Parameter 
Characterized 
Behavior/Properties 
Interpretation 
Indentation 
Creep SRS 
Exponent 
Viscoplasticity 
 
Equation: 𝑚 =
𝜕[𝑙𝑛𝐻(𝑡)]
𝜕[𝑙𝑛?̇?𝐻(𝑡)]
 
 
Exponent describes time-dependent plasticity 
under constant stress.  
 
ΔSFfinal Viscoelasticity 
 
Equation: ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 = 𝑆𝐹𝑐/𝑑 − 𝑆𝐹𝑜𝑢𝑡−𝑜𝑓−𝑑𝑖𝑒 
 
Value characterizes time-dependent elasticity 
occurring post-decompression.  
 
Heckel-Based 
SRS Index 
Non-specific assessment 
of strain rate sensitivity  
 
Equation: 𝑆𝑅𝑆 (%) =
𝑃𝑦2−𝑃𝑦1
𝑃𝑦2
× 100 
 
Index reflects the percent change in 
permanent/reversible deformation occurring 
between two compression speeds.  
 
 
 Each strain rate sensitivity characterization approach presented in Section 1.3.2 
relied on single parameter values in an attempt to describe the complexity of time-
dependent deformation. This approach lacks the necessary detail to differentiate the effect 
of strain rate on elastic deformation from the effects on plastic deformation. As a result, it 
is hypothesized that a multi-component assessment of strain rate sensitivity enables 
identification of the specific mechanical behaviors responsible for observed sensitivity.   
 
 62 
3.1 Experimental 
3.1.1 Materials 
 The excipients studied in the remainder of this dissertation were chosen based on 
their varied deformation behavior. Included in this list are the three materials (highlighted 
red) that were studied on the compaction simulator in Chapter 2. To reiterate, due to time 
constraints on the compaction simulator, only those three materials were studied at high-
speed. Lab-scale data was collected on a wider range of excipient powders. Raw material 
supplier information for each of the six excipients is provided in Table 9. 
 
Table 9. Raw material supplier information 
Material (Trade name) 
Supplier 
(Location) 
Lot # 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
 
Roquette (Keokuk, IA) E2517 
 
Partially pre-gelatinized 
corn starch (Starch 1500®) Colorcon (West Point, PA) IN514248 
 
Microcrystalline cellulose 
(Avicel® PH 200) FMC Corporation (Philadelphia, PA) PN12824026 
 
Spray-dried lactose 316 
Grade Foremost Farms (Baraboo, WI) 8512021961 
 
anhydrous lactose 120 MS Kerry Bio-Sciences (Norwich, NY) 1320000873 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
JRS Pharma (Germany) 
 
7089X 
 
  
 Each of the excipients in the preceding table were incorporated into separate base 
formulations along with an internally blended binder, glidant, and lubricant as presented 
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in Chapter 2. The composition of the base formulation remained the same and can be 
referenced in Table 3. In an attempt to limit the variability resulting from disparities in 
physical properties on the compaction behavior of these materials, all experimentation 
was carried out using powders with equivalent particle size ranges (180 - 250 μm) which 
were equilibrated at ambient temperature (~ 23 – 25 ˚C) in a controlled relative humidity 
environment (saturated MgCl2, ~ 32 – 33 % relative humidity [101]).  
 
3.1.2 Data Collection 
3.1.2.1 Raw Material Characterization 
 The excipients that weren’t compacted on the simulator were characterized for 
their true density, moisture content, and particle size distribution. True densities were 
determined by helium pycnometry (Model: SPY-6DC, Quantachrome Instruments, 
Boynton Beach, FL) and performed in triplicate for each excipient. Inherent moisture 
content after equilibration was quantified using loss on drying measurements (Computrac 
Max 2000 Moisture Analyzer, Arizona Instruments, Phoenix AZ) of accurately weighed 
powders. Samples (1.5 – 2.0 g) were heated to 105 ˚C and held isothermally until the rate 
of moisture loss was less than 0.1 %/min. Sieve analysis (Performer III Model: SS-3, 
Gilson Company, Lewis Center, OH) was used to determine the particle size distributions 
of 50 g of powder. Collected fractions ( >1000, 1000-500, 500-250, 250-180, 180-125, 
125-75, 75-53, and <53 μm) were weighed at intervals ranging from 5 to 15 min until the 
measured weight change was less than 0.1 g.  
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3.1.2.2 Tablet Compaction  
 Formulations were prepared by blending powders in 5 g batches using a small-
scale rotary mixer (Appropriate Technical Resources (ATR), Model # 10101). The 
blending protocol consisted of an initial 15 min blend period, followed by blending for an 
additional 2 min after addition of magnesium stearate. An Instron universal testing 
system (Model 5869, Instron Corporation, Norwood, MA) equipped with a 50 kN load 
cell was used to compact each formulation into tablets. Each tablet was prepared by 
weighing 500 mg of powder into a 13-mm stainless steel, cylindrical die. The 
measurement accuracy of the Instron was within ± 0.5 % of the maximum applied load 
and ± 0.02 mm of the maximum recorded displacement. 
 A total of 10 tablets were prepared with each material. First, a single tablet was 
compacted to a maximum pressure of 264 MPa at 0.04 mm/s for all materials. The in-die 
data from these tablets were used to determine the pressures needed to compact each 
material to an out-of-die porosity of 20 ± 2 %, after relaxation. Then, six tablets were 
tableted using the maximum pressure identified from the data correction procedure for 
that material. All tablets were prepared at a compaction speed of 0.04 mm/s. With the 
remaining material from each blend, 3 additional tablets were compacted to the same 
maximum applied pressure using a linear compaction speed of 4 mm/s. It was observed 
that complete relaxation of formed tablets occurred within 7 to 10 days. The final 
dimensions of each tablet were measured using a digital caliper (Model CO 030150, 
Marathon).  
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3.1.2.3 Tablet Indentation 
 A Vickers diamond-pyramid tip indenter was used to apply a constant load of  
10 ± 0.1 N for 60 s. An Instron universal material testing system was operated using a 
highly sensitive load cell (50 N) with a loading and unloading rate of 10 N/min. 
Extension values were measured using a deflectometer (Model I3540-015T-ST) 
positioned as near to the indenter tip as possible. This transducer has a fixed body with a 
moving core. The moving core is spring loaded and features a ball-tip. Any movement of 
the area of interest is transferred to the moving tip and hence to the transducer resulting in 
a signal that is proportional to the deflection. 
 3 of the 6 tablets compacted at 0.04 mm/s, whose out-of-die porosity deviated the 
least from 20 %, were chosen for the indentation experiments. Replicate indentations  
(n = 5) were performed on the upper surface of each tablet. A total of 15 indentations 
were analyzed for determining the Indentation Creep SRS Exponent. The position of the 
indentations was consistent but the sequence in which the indentations were formed was 
random. Instron Bluehill® 2 software (Version 2.17) was used to collect raw data during 
the indentation creep experiments.   
 
3.1.3 Data Analysis 
3.1.3.1 Indentation Creep SRS Exponent  
 Raw data outputs for the indentation creep studies included: time (s), load (N), 
and extension (mm) measured using a deflectometer. A typical plot of extension versus 
time for Lycatab® PGS is provided in Figure 20. 
 66 
 
Figure 20. Extension versus time profile for Lycatab® PGS collected during the 60 
second hold region 
  
 For each indentation measurement the tablet surface was manually detected in 
order to reset to the ‘zero’ extension position. As a result, all extension values measured 
by the deflectometer and recorded by the software had a negative sign designation. 
Accordingly, an extension value of -0.2 mm indicates that the position of the indenter tip 
is 0.2 mm below the tablet surface. It was noticed for materials that showed relatively 
small amounts of creep, extension values changed by discrete steps as the time under load 
increased. An extension versus time profile for Emcompress® is provided in Figure 21 to 
illustrate this phenomenon.  
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Figure 21. Extension versus time profile for Emcompress® collected during the 60 second 
hold region 
 
 This behavior was not unexpected given how little those materials deform under 
constant stress conditions and the sensitivity of the deflectometer to displacement. 
However, non-continuous data becomes quantitatively problematic for calculating 
indentation strain rate (Eq. (14)). Determining (
𝑑ℎ
𝑑𝑡
) using the raw data (Figure 21) is 
complicated by the fact that extension appears to remain constant for periods of time 
between step changes in position. As a result, extension-time data recorded during the 
hold region of the creep test were fit to a fractional order polynomial (Eq.(21), following 
page) using non-linear least squares regression. Use of this equation to fit indentation 
extension-time data has been published previously [91]: 
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 ℎ = ℎ𝑖 + 𝑎(𝑡 − 𝑡𝑖)
1/2 + 𝑏(𝑡 − 𝑡𝑖)
1/4 + 𝑐(𝑡 − 𝑡𝑖)
1/8 + 𝑑(𝑡 − 𝑡𝑖)
1/16 (21) 
 
where ℎ𝑖 is the initial extension at the start of the hold region, 𝑡𝑖. Fitting constants [𝑎 −
𝑑] were solved for by minimizing the sum of squares between the recorded and curve fit 
extension values. Quality of fit is depicted graphically in Figures 22 and 23. 
  
 
Figure 22. Curve fit function (―) overlaid with recorded data (◊) for Emcompress® 
collected during the 60 second hold region 
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Figure 23. Curve fit versus recorded extension values for Emcompress® collected during 
the 60 second hold region. The data collected at the start of the hold region is plotted in 
the upper right corner and proceeds diagonally with time 
 
 This curve fitting procedure produces a continuous function that is consistent with 
the measured compressive extension values without the original granularity (Figure 22). 
There is also a good agreement between the actual and predicted extension values (Figure 
23). These data suggest that the continuous function accurately describes the recorded 
data. It should be made clear that this function (Eq. (21)) was used strictly for its ability 
to fit the data for all materials and not because it has any physical significance.  
 The next step for determining the Indentation Creep SRS Exponent was to 
calculate hardness using the relationship presented in Eq. (13). Hardness, 𝐻(𝑡), is 
determined by dividing the applied load, or force, by the area over which that force is 
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being distributed. Under the experimental conditions used in this dissertation, the 
definition of hardness is based on the contact area under load. This deviates slightly from 
the traditional hardness measurement that uses residual contact area, but by using this 
approach the time-dependency of hardness could be assessed. As mentioned previously, a 
Vickers diamond- pyramid tip indenter (Figure 24) [109] was used for all indentation 
creep experiments.  
 
 
Figure 24. Vickers diamond-pyramid tip indenter geometry and area of indentation  
(Re-printed with permission from the publisher [109]) 
 
 Area of contact was determined from the inherent geometry of the indenter tip 
and the indenter depth, ℎ𝑝, as the indenter penetrated the surface. For the Vickers 
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diamond-pyramid geometry, area of contact (𝐴) was calculated according to Eq. (22) 
[109]:   
 
 𝐴 = 4ℎ𝑝
2 tan2 68° (22) 
which reduces to Eq. (23): 
 𝐴 = 24.504ℎ𝑝
2
 (23) 
 
 An example indentation hardness versus time profile for Lycatab® PGS is 
provided in Figure 25 to illustrate the relationship between these variables.  
 
Figure 25. Indentation hardness versus time profile for Lycatab® PGS collected during 
the 60 second hold region 
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 Indentation hardness decreases as a function of hold time because the projected 
area of the indentation is increasing as the indenter tip further penetrates the sample. 
Inherently, the test method is designed to test under constant stress conditions. As the 
projected area of the indentation increases, calculated hardness values decrease due to 
progressively dividing by a larger area (Eq. (13)).  
 Indentation strain rate was calculated by solving Eq. (14) at each time point. The 
(
𝑑ℎ
𝑑𝑡
) values were determined by computing the instantaneous rate of change of the 
polynomial function (Eq.(21)) fit to the extension versus time data. A typical plot of 
indentation strain rate versus time for Lycatab® PGS is provided in Figure 26. 
 
Figure 26. Indentation strain rate versus time profile for Lycatab® PGS collected during 
the 60 second hold region 
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 It was observed, for all materials, that there was an initial transient region where 
the calculated indentation strain rate increased. This was followed by the anticipated 
decrease as the indenter further penetrated the sample. Upon further investigation of the 
data, it was determined that this occurrence was an artifact in the data analysis routine 
rather than a physical phenomenon. During the curve fitting procedure, it was noticed 
that the curve fit function (Eq. (21)) did not describe the data properly in the beginning 
part of the hold region. Figure 27, below, provides an expanded view of the recorded and 
curve fit data plotted previously in Figure 22.  
 
 
Figure 27. Curve fit function (―) overlaid with recorded data (◊) for Emcompress® 
collected during the 60 second hold region. Zoomed in to capture behavior during the 
start of the hold region 
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 It was apparent that the curve fit extension values initially increased (i.e., became 
less negative), rather than decreasing according to the recorded data. This behavior can 
be used to explain the initial increase in indentation strain rate observed in Figure 26.  
Subsequently, the natural logarithm of hardness versus natural logarithm of strain rate 
profile also exhibited uncharacteristic behavior in the data recorded at the start of the hold 
region. For example, the plot for Lycatab® PGS is shown in Figure 28. The entirety of the 
hold region data has been plotted.  
 
 
Figure 28. ln (𝐻) vs. ln (𝜀?́?) profile for Lycatab
® PGS. Entire hold region data has been 
plotted 
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corresponding to positive changes in indentation strain rate were not included in the 
analysis. A representative set of the final data used to determine the Indentation Creep 
SRS Exponent for Lycatab® PGS are plotted in Figure 29. The hold region data, 
excluding the transient region, have been plotted.  
 
 
Figure 29. ln (𝐻) vs. ln (𝜀?́?) profile for Lycatab
® PGS exclusive of the transient region 
data 
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the slope is reported throughout this dissertation representing variation between replicate 
indentations on the surface of the same tablet.  
   
3.1.3.2 ΔSFfinal 
 ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values were determined from the solid fraction data correction methods 
presented in detail in Appendix A. In the data presented in Appendix A, the maximum 
applied pressure used to determine ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 was 264 MPa. However, it is important to 
note that the ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 designation does not necessarily always correspond to tablets 
compressed to a maximum pressure of 264 MPa. When the correction method was 
applied moving forward, ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 simply applies to the maximum pressure used to form 
any tablet, even if that pressure changes between materials. Viscoelastic recovery can be 
assessed from any level of applied pressure. For consistency, the change in solid fraction 
due to viscoelastic recovery from the maximum applied pressure will still be termed 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 even though a maximum applied pressure of 264 MPa was not always used. 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values (n = 6) in this chapter correspond to the maximum applied pressure used 
to compact each material at 0.04 mm/s to a consistent porosity of 20 ± 2 %. Those 
applied pressures are reported in Table 13.  
 The difference between 𝑆𝐹𝑐/𝑑, or the elasticity corrected solid fraction, and the 
measured out-of-die solid fraction can be attributed to recovery that occurs after 
decompression. These differences are presented in Figure 30 for all materials studied in 
the original work describing this method.  
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Figure 30. Viscoelastic recovery versus pressure profiles for Lycatab® PGS (□). Avicel® 
PH200 (◊), Lactose 316 (○), and Emcompress® (ӿ). ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values are labeled 
 
 It is evident that the amount of viscoelastic recovery observed in these data is not 
significantly dependent on applied pressure. Using the difference in solid fraction 
observed at the highest pressure (∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙), the 𝑆𝐹𝑐/𝑑 data can be corrected for changes 
associated with time-dependent reversible deformation. Average ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values for each 
material can be found in Table 10, on the following page. The 𝑆𝐹𝑐/𝑑 and out-of-die solid 
fraction values, from which ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 is calculated, have also been provided. 
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Table 10. Summary of reversible and time-dependent deformation data 
Material 𝑆𝐹𝑐/𝑑
a Out-of-die SFa ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙
a 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
 
0.939 (0.002) 
 
0.824 (0.006) 
 
0.1163 (3E-04) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.938 (0.002) 
 
0.899 (0.005) 
 
0.0410 (3E-05) 
 
Spray-dried lactose 316 
Grade 
 
0.890 (0.002) 
 
0.887 (0.007) 
 
0.0028 (1E-05) 
 
Dibasic calcium 
phosphate dihydrate 
(Emcompress®) 
 
0.813 (0.001) 
 
0.824 (0.001) 
 
-0.0136 (2E-06) 
 
aAverage and standard deviation of three replicate tablets compressed to 264 MPa 
 
 Positive values of ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 indicate that the solid fraction decreased after being 
ejected from the die. As expected, the ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 value for Lycatab
® PGS is the largest 
because of its viscoelastic nature. Those materials that experience a large reduction in 
solid fraction due to radial and axial expansion of the tablet dimensions will 
characteristically have large ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values. Conversely, Emcompress
® and lactose 316 
show virtually no viscoelastic recovery, post-ejection, so it is expected to see ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
values close to zero. The solid fraction curves for lactose 316 are plotted in Figure 31, on 
the following page.  
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Figure 31. In-die (―), elasticity corrected (•••), viscoelasticity corrected (– •–), and out-
of-die (□) solid fraction versus pressure profiles for Lactose 316 compacted at 0.04 mm/s 
 
 As expected, the 𝑆𝐹𝑐/𝑑, 𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑, and out-of-die solid fraction curves for this 
material are virtually superimposable. Since the ejected tablets do not show extensive 
recovery, the measured out-of-die solid fraction was nearly identical to the elasticity 
corrected data. The reported error associated with average  ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values reported 
throughout this chapter represents the variation in viscoelastic recovery between replicate 
tablets.  
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in-die values, proper corrections for machine part deformation were required for accurate 
measurement of powder bed height. This correction was performed according to the 
methods presented previously in Chapter 2 Section 2.1.2.5. Using the corrected punch 
separation data, in-die solid fraction was calculated according to Eq. (17), where 𝑡 is the 
thickness of the powder bed rather than the thickness of an ejected tablet.  
 An example in-die solid fraction versus compaction pressure profile for 
Emcompress® compacted at 4 mm/s is provided in Figure 32 to illustrate the relationship 
between these variables.  
 
 
Figure 32. In-die solid fraction versus pressure profile for Emcompress® compacted at 4 
mm/s 
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 Solid fraction was converted to porosity using Eq. (7) provided in Chapter 1 and 
was plotted as a function of compaction pressure in Figure 33. Provided the relationship 
between porosity and solid fraction, it makes sense that porosity, or pore space, decreases 
as pressure increases. Powder particles are brought into increasingly closer contact 
decreasing the space between them. 
 
 
Figure 33. In-die porosity versus pressure profile for Emcompress® compacted at 4 mm/s 
 
 In order to calculate mean yield pressure, porosity-pressure data were transformed 
by taking the negative natural logarithm of porosity (Eq.(8)). An in-die Heckel profile for 
Emcompress® is provided in Figure 34, on the following page. 
0.0
0.2
0.4
0.6
0.8
1.0
0 50 100 150 200 250
P
o
ro
si
ty
Compaction Pressure (MPa)
 82 
 
Figure 34. In-die Heckel profile for Emcompress® compacted at 4 mm/s 
 
 The next step was to determine the appropriate linear range in Figure 34 for 
calculating mean yield pressure. Several methods for determining the linear range exist in 
the literature and are used often [12,110]. While no single method is universally utilized, 
the reproducibility of the result is certainly a function of the consistency of the analysis. 
For that reason, Heckel data in this work were considered linear when the first derivative 
showed less than 15 % variation. In order to compare yield pressure values, the same 
pressure range that was determined for the tablets compacted at 0.04 mm/s was used for 
the tablets prepared at 4 mm/s. Values of mean yield pressure were obtained for each 
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Index, mean yield pressure values for both speeds were used with Eq. (11), and the 
percentage change was computed.  
 The error associated with this measurement was determined by propagating the 
uncertainties of the slow and fast mean yield pressures. Each numerical operation in Eq. 
(11) has an uncertainty associated with its value.  The equation used to calculate each 
uncertainty is presented in Eq. (18) for the subtraction of 𝑃𝑦1 from 𝑃𝑦2, and in Eq.(19) for 
the division of this difference by 𝑃𝑦2: 
  
 𝜎(𝑃𝑦2̅̅ ̅̅ ̅−𝑃𝑦1̅̅ ̅̅ ̅) = √(𝜎𝑃𝑦2)
2 + (𝜎𝑃𝑦1)
2 (18) 
   
 𝜎
(
𝑃𝑦2̅̅ ̅̅ ̅̅ −𝑃𝑦1̅̅ ̅̅ ̅̅
𝑃𝑦2̅̅ ̅̅ ̅̅
)
= √(
𝜎𝑃𝑦2−𝑃𝑦1
𝑃𝑦2̅̅ ̅̅ ̅−𝑃𝑦1̅̅ ̅̅ ̅
)2 + (
𝜎𝑃𝑦2
𝑃𝑦2̅̅ ̅̅ ̅
)2 (19) 
 
where, for example, 𝑃𝑦2̅̅ ̅̅  corresponds to the average mean yield pressure for tablets 
compressed at 4 mm/s, and 𝜎𝑃𝑦2 indicates the standard deviation of mean yield pressure 
at the same speed.  
 
3.2 Results and Discussion 
3.2.1 Raw Material Characterization 
 Summarized data for powder true density and moisture content for all six 
excipients is provided in Table 11, on the following page. 
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Table 11. Individual component true density and moisture content values 
Formulation’s Primary Ingredient True density % Moisturea (S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 1.458 (0.004)  8.408 (0.066) 
 
Partially pre-gelatinized corn starch  
(Starch 1500®) 1.493 (0.003)  8.486 (0.077) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
1.550 (0.004) 5.672 (0.040) 
 
Spray-dried lactose 316 Grade 
 
1.531 (0.005) 
 
0.360 (0.066) 
 
Anhydrous lactose 120 MS 
 
1.549 (0.005) 
 
0.090 (0.031) 
 
Dibasic calcium phosphate dihydrate 
(Emcompress®) 
 
2.301 (0.002) 
 
3.130 (0.058) 
 
a Loss on drying 
   
 As before, true density values for each formulation were determined from the true 
density of the individual materials according to the weight fraction of each component. 
Particle size distribution, given as percent undersize for each of the six materials is listed 
in Table 12, on the following page.  
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Table 12. Individual component particle size distribution determined by sieve analysis 
 Percentage undersize 
Material 
<53 
μm 
<75 
μm 
<125 
μm 
<180 
μm 
<250 
μm 
<500 
μm 
<1000 
μm 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 22.8 22.8 27.7 49.8 77.8 95.0 99.9 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 43.8 43.8 48.5 87.9 98.5 99.8 99.8 
 
Microcrystalline cellulose 
(Avicel® PH 200) 7.2 7.2 8.9 18.5 32.7 60.3 100.0 
 
Spray-dried lactose 316 Grade 
 
8.8 
 
8.9 
 
13.9 
 
47.6 
 
90.0 
 
99.9 
 
99.9 
 
anhydrous lactose 120 MS 
 
4.7 
 
4.7 
 
7.6 
 
66.6 
 
89.5 
 
98.7 
 
99.9 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
1.0 
 
1.0 
 
2.4 
 
14.3 
 
29.8 
 
84.9 
 
98.1 
 
 
 Reported values for the Indentation Creep SRS Exponent and ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 represent 
data collected on tablets (n = 6) compressed at 0.04 mm/s. Additional tablets (n = 3) were 
compressed at 4 mm/s in order to derive the mean yield pressure at fast speed for 
computing the Heckel-Based SRS Index. Maximum compaction pressures and average 
out-of-die porosities for each individual component are reported in Table 13. 
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Table 13. Individual component out-of-die porosity values (0.04 mm/s) 
Individual Component 
Maximum Compaction 
Pressure (MPa) 
Out-of-die Porosity 
(S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
226.0 
 
0.188 (0.002) 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 105.5 0.196 (0.001) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 97.9 0.188 (0.006) 
 
Spray-dried lactose 316 Grade 105.5 0.195 (0.002) 
 
anhydrous lactose 120 MS 75.3 0.197 (0.006) 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
226.0 
 
0.186 (0.002) 
 
  
3.2.2 Indentation Creep SRS Exponent 
 Creep behavior describes the tendency of materials to exhibit continuing 
deformation under constant stress conditions [111]. Displacement values recorded at each 
time increment are due to the creep properties of the material. This behavior was 
confirmed by examining the extent of creep displacement for Lycatab® PGS, Avicel® PH 
200, and Emcompress® under constant load. These data are plotted in Figure 35, provided 
on the following page.    
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Figure 35. Displacement versus time profiles for Lycatab® PGS (◊), Avicel® PH200 (Δ) 
and Emcompress® (□) collected during the 60 second hold region 
 
 During the 60 s hold time, the indenter tip penetrates the compact’s surface as 
particles creep into empty pores beneath the indenter. Materials that deform via a plastic 
deformation mechanism, Lycatab® PGS and Avicel® PH200 for example, showed greater 
creep compared to a brittle material, such as Emcompress®. During the hold period, 
Lycatab® PGS showed the largest average displacement of the materials studied, creeping 
0.014 mm. In comparison, Emcompress® showed an order of magnitude less average 
creep during indentation. The indentation creep data were used in this work to evaluate 
time-dependent plasticity, or viscoplasticity. Materials will exhibit a time-dependent 
mechanical response depending on the predominant mode by which it deforms. These 
data not only offer the ability to differentiate brittle materials from plastic materials, but 
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also offer the ability to see differences between materials with the same predominating 
deformation mechanism.  
 Figures 36-38 provide example plots of the natural logarithm of hardness (𝐻) as a 
function of the natural logarithm of strain rate (𝜀?́?) for three of the six materials studied. 
The material showing the most creep (Lycatab® PGS), a material showing intermediate 
creep behavior (Avicel® PH200), and the material which showed minimal creep 
(Emcompress®), have been selected. These materials also correspond to the same three 
materials studied on the compaction simulator in Chapter 2. Linear regression lines were 
fit to the data, and the Indentation Creep SRS Exponent is emphasized in bold.  
 
 
Figure 36. ln (𝐻) vs. ln (𝜀?́?) profile for Lycatab
® PGS 
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Figure 37. ln (𝐻) vs. ln (𝜀?́?) profile for Avicel
® PH200 
 
Figure 38. ln (𝐻) vs. ln (𝜀?́?) profile for Emcompress
®  
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 After transitioning from loading the indenter to holding the constant load, the 
relationship between hardness and strain rate became consistent. Beyond the transient 
region, linear relationships between the transformed values of hardness and strain rate 
were generally observed. The strain rates observed during the indentation creep studies 
are controlled by the materials themselves, depending directly on the material’s ability to 
deform. In this work, the ranges of strain rates were consistent, allowing for comparison 
of time-dependent plasticity between materials. 
 Table 14 provides a summary of the indentation creep results for all materials 
studied. The table contains the Indentation Creep SRS Exponent used to evaluate time-
dependent plasticity and the average hardness values at the start of the hold region. 
 
 Table 14. Individual component summary of indentation creep results 
Material 
Indentation Creep  
SRS Exponent (S.D.) 
Hardness at Start of 
Hold Region (MPa) 
(S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
0.052 (0.006) 
 
12.3 (1.1) 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 
 
0.039 (0.003) 
 
22.4 (2.4) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.028 (0.002) 
 
24.2 (3.1) 
 
anhydrous lactose 120 MS 
 
0.026 (0.003) 
 
36.0 (6.4) 
 
Spray-dried lactose 316 
Grade 
 
0.019 (0.002) 
 
35.8 (5.3) 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
0.016 (0.002) 
 
53.7 (8.3) 
 
 91 
 Reported error reflects the standard deviation of 15 indentations made on 3 
different tablets (n = 5 per tablet). Prior to comparing the average Indentation Creep SRS 
Exponent values, an F-test [112] was applied to assess the equality of variance between 
materials. For the F-test, the null hypothesis was that the variances (standard deviation 
squared) were equal; the alternative being that they were unequal. All F-test’s were 
performed at a significance level of α = 0.05. The outcome of the F-test dictated the test 
statistic equation that would be used in the subsequent t-test comparing means.  
 Figure 39 provides a summary of the statistical comparisons. The data is 
presented in matrix form and materials are listed in order of decreasing exponent value. 
Bolded cells in the matrix represent the F-test comparisons that rejected the null 
hypothesis of equal variance.   
 
 Lycatab® 
PGS 
Starch 
1500® 
Avicel® 
PH 200 
anhydrous 
lactose 
lactose 
316 
Emcompress® 
Lycatab®  
PGS 
x      
Starch  
1500® 
YES x     
Avicel®  
PH 200 
YES YES x    
anhydrous 
lactose 
YES YES NO x   
lactose  
316 
YES YES YES NO x  
Emcompress® YES YES YES YES NO x 
 
Figure 39. Statistical summary matrix: Indentation Creep SRS Exponent. Green ‘YES’ 
boxes indicate statistically significant differences, and Red ‘NO’ boxes indicate statistical 
equivalence. Bolded cells indicate the comparisons that had unequal variance 
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 Statistically significant differences for the t-test [112] are represented by the green 
colored boxes in the matrix. Since multiple comparisons were made, a Bonferroni 
correction [113] was applied to adjust the critical P value (α). The original significance 
level, α = 0.05, was divided by the number of comparisons (n = 15) to obtain the new 
critical P value. The rank order of the materials from highest to lowest viscoplasticity 
was: Lycatab® PGS, Starch® 1500, Avicel® PH 200, Anydrous lactose, lactose 316, and 
Emcompress®. The values for the Indentation Creep SRS Exponent ranged from 0.016 
for Emcompress® to 0.052 for Lycatab® PGS (Table 14). Larger SRS Exponent values 
indicate larger amounts of time-dependent plastic deformation, or viscoplasticity.  
 It is commonly accepted that plastically deforming materials tend to be more 
sensitive to strain rate than brittle materials. Plastic particles are able to flow into void 
spaces; increasing particle-particle contact and relieving local stress. The strain 
associated with plastic deformation is time-dependent based on how fast the particles can 
flow. On the other hand, predominantly brittle particles fragment into smaller pieces that 
then repack themselves into a more dense arrangement. As fragmentation is typically 
very rapid, brittle materials will register very little change in strain after the beginning of 
the hold period.  
 In addition to differentiating between brittle and plastic materials, the indentation 
creep method can also differentiate between materials having the same predominating 
deformation behavior. Take, for example, the comparison of Lycatab® PGS with Avicel® 
PH200. Out-of-Die Heckel Slope values, determined according to the methods presented 
in Appendix A, were used to identify a materials predominant deformation behavior. The 
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average Out-of-Die Heckel Slopes for Lycatab® PGS and Avicel® PH200 are provided in 
Table 15.  
 
Table 15. Average Out-of-Die Heckel Slope Values derived from in-die data 
Material Out-of-Die Heckel Slope (S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
0.0111 (0.0004) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.0111 (0.0006) 
 
 
 Of the materials tested, these two had the highest measured Out-of-Die Heckel 
Slopes derived from in-die data. Larger slopes signify a greater reduction in porosity with 
pressure and are observed for materials whose deformation is dominated by plastic flow. 
The irreversible deformation behavior of these two materials is the same, both being 
highly plastic. However, when comparing the indentation creep data (Table 14), the 
plastic behavior of Lycatab® PGS was much more strain rate sensitive. Lycatab® PGS 
had an average Indentation Creep SRS Exponent of 0.052, nearly double the average 
slope of Avicel® PH 200 which was measured at 0.028. This difference suggests that 
although Avicel® PH200 is characterized as being highly plastic, that behavior is not 
nearly as affected by strain rate changes as is the plasticity of Lycatab® PGS. Subtle 
differences between materials can be identified using the indentation creep method.  
 In the practical sense, the ability to pinpoint differences in time-dependent 
plasticity between materials with the same predominating deformation mechanism is of 
significant value. While the common perception is that a highly plastic material will 
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require additional time for its particles to flow under higher speed compaction conditions, 
the degree to which that behavior is sensitive can vary. If it is observed that a plastic 
material is not highly strain rate sensitive, it is less likely for that material to behave 
differently upon scale-up.  
 
3.2.3 ΔSFfinal 
 In addition to assessing the time-dependent permanent deformation tendencies of 
a material, it is equally important to understand how the compacted particles behave post-
compaction. Elastic deformation is characterized by the storage and release of applied 
stresses upon decompression. For some materials the extent of elastic strain is recovered 
immediately, but for others this process is time-dependent. All pharmaceutical materials 
are considered to be viscoelastic, but to varying degrees [41]. A highly viscoelastic 
material will deform extensively over time as the dimensions of the tablet increase in 
both the axial and radial directions.  
 Viscoelastic tendency of each material was assessed by computing the change in 
solid fraction of a tablet over time. Briefly, ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values represent the difference 
between the maximum elasticity corrected solid fraction, 𝑆𝐹𝑐/𝑑, and the out-of-die solid 
fraction measured from the same tablet [114,115]. ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 is an empirical parameter that 
captures the extent to which a material displays time-dependent reversible deformation 
during storage, post-ejection. A large positive value indicates that a larger reduction in 
solid fraction is experienced over time as the tablet recovers. Values close to zero are 
interpreted as the dimensions of the tablet in the die after decompression being nearly 
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equivalent to the dimensions of the tablet once it has been ejected and allowed to recover 
over time. The summary results for ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 are presented in Figure 40. 
 
 
Figure 40. Individual component ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values. Data bars represent average values (n = 
6) and associated error bars represent standard deviation 
 
 ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values ranged from 0.120 for Lycatab
® PGS to 0.001 for anhydrous 
lactose and Emcompress®. The error reported for average ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values reflect the 
standard deviation of six replicate tablets. As before, equality of variance was assessed 
using an F-Test prior to a t-Test comparing the average ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values. The same 
statistical testing procedures, presented in detail in Section 3.2.2, were used to compare 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 data. Figure 41 provides a summary of the statistical comparisons. Materials are 
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listed in descending order of average ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 value.  Bolded cells in the matrix represent 
the F-test comparisons that rejected the null hypothesis of equal variance.   
 
 Lycatab® 
PGS 
Starch 
1500® 
Avicel® 
PH 200 
lactose 
316 
anhydrous 
lactose 
Emcompress® 
Lycatab®  
PGS 
x      
Starch  
1500® 
YES x     
Avicel®  
PH 200  
YES YES x    
lactose  
316 
YES YES NO x   
anhydrous 
lactose 
YES YES YES YES x  
Emcompress® YES YES YES YES NO x 
 
Figure 41. Statistical summary matrix: ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙. Green ‘YES’ boxes indicate statistically 
significant differences, and Red ‘NO’ boxes indicate statistical equivalence. Bolded cells 
indicate the comparisons that had unequal variance 
  
 Significant differences (green boxes) in ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 were observed for all 
comparisons except Avicel® PH 200 compared to lactose 316 and anhydrous lactose 
compared to Emcompress® (red boxes). Since both anhydrous lactose and Emcompress® 
show virtually no viscoelastic recovery it was not unexpected to see their values be 
statistically similar. Both starches, Lycatab® PGS and Starch 1500®, where the most 
viscoelastic which corresponds to previously published reports on these materials 
[9,44,84,106]. Therefore, the rank order of viscoelastic-tendency is: Lycatab® PGS, 
Starch® 1500, Avicel® PH 200/lactose 316, and anhydrous lactose/Emcompress®.  
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 A material’s strain rate sensitivity can be due to changes in viscoelasticity or due 
to changes in viscoplasticity at different speeds. Therefore, there exists a need to 
characterize the sensitivity of both irreversible and reversible deformation. ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
values offer the potential to assess changes in viscoelastic behavior that correspond to 
changes in tablet press speed. In other words, the larger ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙, the more strain rate 
sensitive a materials reversible deformation is. 
 From a characterization prospective, utilizing methods that can differentiate 
between the specific mechanical behaviors that contribute to a material’s strain rate 
sensitivity is imperative. A more comprehensive understanding of time-dependent 
deformation can be obtained using methods that are more specific. Due to the complexity 
of strain rate sensitivity, it is not enough to simply classify a material or formulation as 
being strain rate sensitive, or not. Identifying the mechanical behaviors that contribute to 
observed sensitivity will lead to more informed decisions during formulation 
development. 
   
 3.2.4 Heckel-Based SRS Index 
 A material’s strain rate sensitivity can be due to changes in viscoplasticity, 
viscoelasticity, or both as the tablet press speed used to prepare that material changes. 
The individual parameters presented in Sections 3.2.2 and 3.2.3 can be used to identify 
the contributing behavior, or behaviors. What these parameters don’t account for is how 
those behaviors manifest during preparation of a tablet at a slow speed compared to 
preparation of the same material at high speed. As a result, additional strain rate 
sensitivity characterization included evaluating material densification behavior during 
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compaction at two different tablet press speeds. Roberts and Rowe developed the Heckel-
Based SRS Index as a method for material comparison and as a tool to improve 
understanding of the effects of strain rate on deformation.   
 The densification behavior of two materials, one that is strain rate sensitive and 
one that is insensitive are shown in Figures 42 and 43, respectively. The figure legend 
represents the linear compaction speed used to form those tablets. 
 
 
Figure 42. In-die Heckel plots for Starch 1500® compacted at 0.04 mm/s (―) and 4 mm/s 
(―) 
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Figure 43. In-die Heckel plots for Emcompress® compacted at 0.04 mm/s (―) and 4 
mm/s (―) 
 
 Both materials exhibit a reduction in porosity as compaction pressure is increased. 
The deformation behavior of Starch 1500®, whose irreversible deformation is 
predominantly plastic, was affected by press speed changes. At slower speed (0.04 mm/s) 
Starch 1500® consolidated to a greater extent as more time was allowed for deformation 
to occur. Conversely, Emcompress® is a brittle material whose extent of deformation was 
not affected by compaction speed. Deformation occurs by fragmentation of the original 
particles into smaller, discrete units that pack together more densely. Fragmentation 
occurs rapidly and is not significantly affected by the amount of time over which pressure 
is applied. Therefore, density-pressure behavior of a brittle material will remain 
consistent as the compression speed changes. 
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 Table 16 provides a summary of the Heckel analysis results for each material 
tested. The table contains the upper and lower pressure values corresponding to the linear 
range, the mean yield pressure determined at both slow and fast speeds and the Heckel-
Based SRS Index derived from the mean yield pressure values.  
 
Table 16. Individual component summary of Heckel analysis results  
  0.04 mm/s 4 mm/s  
Material 
(Lower – Upper) 
Pressure (MPa) 
Mean Yield 
Pressure 
(S.D.) 
(MPa) 
Mean Yield 
Pressure 
(S.D.) 
(MPa) 
Heckel-
Based SRS 
Index 
(S.D.) 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
75-125 
 
43.0 (1.7) 
 
49.7 (1.3) 
 
13.5 (3.4) 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 
 
15-60 
 
51.9 (1.7) 
 
68.0 (1.0) 
 
23.6 (2.5) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
35-80 
 
51.6 (1.2) 
 
57.1 (1.5) 
 
9.6 (4.0) 
 
Spray-dried lactose 316 Grade 
 
40-100 
 
75.7 (1.8) 
 
81.5 (1.5) 
 
7.1 (3.5) 
 
anhydrous lactose 120 MS 
 
30-75 
 
86.3 (2.0) 
 
88.2 (2.2) 
 
3.4 (2.2) 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
125-200 
 
349.9 (5.4) 
 
345.0 (6.6) 
 
-- 
 
 
  
 The materials ranged in strain rate sensitivity from ~0 % for Emcompress® to 23.6 
% for Starch 1500®. Standard deviation reported for the mean yield pressures reflects the 
variation between three tablets compacted at each speed. Error reported for the Heckel-
Based SRS Index reflects the propagated uncertainty of the slow and fast mean yield 
pressures.  
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 Equality of variance was assessed using an F-Test prior to a t-Test comparing the 
average Heckel-Based SRS Index values between materials. Statistical significance 
testing was performed using the same methods presented for similar tests in Section 
3.2.2. Figure 44 provides a summary of the statistical comparisons. The data is presented 
in matrix form and materials are listed in order from largest to smallest Heckel-Based 
SRS Index. Bolded cells in the matrix represent the F-test comparisons that rejected the 
null hypothesis of equal variance.     
 
 Starch 
1500® 
Lycatab® 
PGS 
Avicel® 
PH 200 
lactose 
316 
anhydrous 
lactose 
Emcompress® 
Starch  
1500® 
x      
Lycatab®  
PGS 
YES x     
Avicel®  
PH 200 
YES NO x    
lactose  
316 
YES NO NO x   
anhydrous 
lactose 
YES YES NO NO x  
Emcompress® YES YES YES YES YES x 
 
Figure 44. Statistical summary matrix: Heckel-Based SRS Index. Green ‘YES’ boxes 
indicate statistically significant differences, and Red ‘NO’ boxes indicate statistical 
equivalence. Bolded cells indicate the comparisons that had unequal variance 
 
 The Heckel-Based SRS Index value for Starch 1500® was statistically different 
(green boxes) than all other materials tested. Several non-significant differences were 
observed (red boxes). Experimental error reported for this index seems to be responsible 
for the statistically insignificant differences between materials. Large errors result from 
the propagated uncertainty of mean yield pressure values (Eq. (18 and 19)). As a result, a 
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fairly large compression speed difference is required to differentiate between materials. A 
100-fold increase in speed was used in this work (0.04 mm/s – 4 mm/s), which is 
significantly less than the nearly 10,000-fold increase used in the original studies 
describing this index [9]. Therefore, a more dramatic compression speed difference 
would be needed to separate Heckel-Based SRS Index statistically, but the trend in the 
data still allows for analysis of material behavior  
 The rank order of the materials from most sensitive to least sensitive was: Starch® 
1500, Lycatab® PGS, Avicel® PH 200, lactose 316, Anydrous lactose, and Emcompress®. 
For the plastically deforming materials, Starch® 1500 and Lycatab® PGS, higher mean 
yield pressures were observed when the compaction speed was increased from 0.04 mm/s 
to 4 mm/s. Increased mean yield pressure values indicate an increased resistance to 
deformation at higher speed. As a result, the consolidation extent of these materials 
decreases. The yield pressures of the more brittle materials, anhydrous lactose and 
Emcompress® lead to insignificant Heckel-Based SRS Index values. 
 It is recognized that the in-die Heckel data used to compute the Heckel-Based 
SRS Index reflects particle deformation by both plastic and elastic mechanisms. 
Therefore, strain rate sensitivity values produced by this method do not distinguish 
between materials whose plastic deformation is strain rate sensitive and those whose 
elasticity is strain rate sensitive (i.e., non-specific). However, utilizing this method to 
measure strain rate sensitivity is still of value. This measurement can be used to identify 
how a material’s deformation behavior will change as a result of changes to tablet press 
speed. For a strain rate sensitive material, the parameter value provides a quantitative 
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measure of the reduction in consolidation exhibited by a material under high-speed 
conditions.   
 
3.3 Summary 
 There exists a need to expand upon traditional characterization techniques. As 
such, the selection of parameters in this chapter was based on their ability to 
comprehensively describe the various aspects of strain rate sensitivity during powder 
compaction. In the simplest terms, the Heckel-Based SRS Index describes how a material 
or formulation behaves at different speeds, while the Indentation Creep SRS Exponent 
and ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 describe why the material or formulation is behaving that way. In an effort 
to provide more specific data for evaluating strain rate sensitivity, parameters that 
describe viscoplasticity (Indentation Creep SRS Exponent) and viscoelasticity (∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙) 
have been introduced.    
 Materials used in this work were carefully selected since materials with a range of 
deformation behaviors were desired. It was thought that by having materials that ranged 
from highly brittle to highly plastic and/or viscoelastic (i.e., Emcompress® to Lycatab® 
PGS), the range of observed strain rate sensitivities would capture the expected range for 
a much larger set of pharmaceutical powders. Table 17, on the following page, provides a 
summary of the rank ordered behavior for each of the three specific lab-scale 
measurements. Designations of ‘high’, ‘intermediate’, and ‘low’ in this summary table 
are subjective, but are based on the statistical significance between experimental values 
for that parameter.  
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Table 17. Individual component strain rate sensitive deformation behavior summary 
Individual Component 
Indentation 
Creep SRS 
Exponent 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
Heckel-Based 
SRS Index 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
High 
(0.052) 
High 
(0.120) 
Intermediate 
(13.5) 
 
Partially pre-gelatinized 
corn starch (Starch 1500®) 
High 
(0.039) 
Intermediate 
(0.073) 
High 
(23.6) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
Intermediate 
(0.028) 
Low 
(0.017) 
Intermediate 
(9.6) 
 
Spray-dried lactose 316 
Grade 
Low 
(0.019) 
Low 
(0.013) 
Intermediate 
(7.1) 
 
anhydrous lactose 120 MS 
Intermediate 
(0.026) 
Low 
(0.001) 
 
Intermediate 
(3.4) 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
 
Low 
(0.016) 
 
 
Low 
(0.001) 
 
 
Low 
(--) 
 
  
 By convention, the materials that were more plastic and/or viscoelastic (i.e. 
Lycatab® PGS and Starch 1500®) were characterized as having sensitivity across all 
parameters. The behavior of Avicel® PH 200 was unique, particularly related to the strain 
rate sensitivity of its predominant deformation mechanism. Although this material was 
characterized as being highly plastic, its plasticity was only moderately sensitive 
according to the Indentation Creep SRS Exponent. In terms of the predominantly brittle 
materials that were tested, it was confirmed that their behavior was generally insensitive 
to speed. The lowest experimental values for each of the three parameters were measured 
for the lactose grades and Emcompress®.    
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Chapter 4: Multi-Component Strain Rate Sensitivity Evaluation of 
Individual Components and Simple Mixtures  
   
 
The challenges faced during formulation development have been traditionally 
resolved by including a number of excipients which allow for large-scale manufacturing 
and provide proper functionality of the dosage form after production. Characterization 
data for single materials can be used to guide development studies towards an optimum 
formulation, but the process frequently relies on trial and error approaches. One reason 
for this is that knowledge of how individual material properties contribute to the behavior 
of a mixture is limited. Studying the compaction properties of a mixture is vital for 
improving the efficiency of formulation development. 
With respect to strain rate sensitivity, the question that is most often asked during 
formulation studies is how to mitigate or diminish the sensitivity of the active ingredient? 
In cases where that component is present in a large percentage, it is reasonable to suspect 
that components behavior will significantly influence the behavior of the formulation. In 
these instances it is imperative to formulate such that the sensitivity of this material will 
not lead to tablet defects like capping and lamination during production.  
In this chapter, the strain rate sensitivity of the excipients tested in Chapter 3 will 
be quantified. A composite evaluation of time-dependent deformation will be used to 
describe the mechanical behaviors that are contributing to the observed sensitivity. 
Additionally, a placebo excipient (Lycatab® PGS) was used to simulate the presence of a 
sensitive active ingredient in mixtures with excipients of varied deformation tendency. 
Mixture modeling will be used to predict how much strain rate sensitivity could be 
affected by adding a secondary component with specific sensitivity behaviors. 
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4.1 Experimental 
4.1.1 Materials 
 The same individual components studied in Chapter 3 (Table 9) were further 
evaluated and analyzed in this chapter. Additionally, a set of 15 mixtures containing 
those excipients were tested. For each mixture the same base formulation containing an 
internally blended binder, glidant, and lubricant as presented in Chapter 2 was used 
(Table 3). In an attempt to limit the variability resulting from disparities in physical 
properties on the compaction behavior of these mixtures, all experimentation was carried 
out using powders with equivalent particle size ranges (180 - 250 μm) which were 
equilibrated at ambient temperature (~ 23 – 25 ˚C) in a controlled relative humidity 
environment (saturated MgCl2, ~ 32 – 33 % relative humidity [101]). 
  
4.1.2 Data Collection 
4.1.2.1 Raw Material Characterization 
 Each mixture was characterized for its true density and moisture content. True 
densities were determined by helium pycnometry (Model: SPY-6DC, Quantachrome 
Instruments, Boynton Beach, FL) and performed in triplicate for each mixture. Inherent 
moisture content was quantified using loss on drying measurements (Computrac Max 
2000 Moisture Analyzer, Arizona Instruments, Phoenix AZ) of accurately weighed 
powders. Samples (1.5 – 2.0 g) were heated to 105 ˚C and held isothermally until the rate 
of moisture loss was less than 0.1 %/min. 
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4.1.2.2 Tablet Compaction  
 Mixtures were prepared by blending powders in 5 g batches using a small-scale 
rotary mixer (Appropriate Technical Resources (ATR), Model # 10101). The blending 
protocol consisted of an initial 15 min blend period, followed by blending for an 
additional 2 min after addition of magnesium stearate. An Instron universal testing 
system (Model 5869, Instron Corporation, Norwood, MA) equipped with a 50 kN load 
cell was used to compact each mixture into tablets. Each tablet was prepared by weighing 
500 mg of powder into a 13-mm stainless steel, cylindrical die. The measurement 
accuracy of the equipment used was within ± 0.5 % of the applied load and ± 0.02 mm of 
the recorded displacement. 
 A total of 10 tablets were prepared for each mixture. First, 1 single tablet for each 
mixture was compacted at 0.04 mm/s to a maximum pressure of 264 MPa. The in-die 
data from this compaction cycle was used to determine the approximate pressure needed 
to compact each mixture at 0.04 mm/s to an out-of-die porosity of 20 ± 2 %, post-
relaxation. 6 additional tablets were then prepared by compacting each mixture to the 
identified pressure using a linear compaction speed of 0.04 mm/s (Table 19). With the 
remaining material, 3 additional tablets were compacted to the same maximum applied 
pressure used to prepare the tablets at 0.04 mm/s, instead using a linear compaction speed 
of 4 mm/s. It was observed that complete relaxation occurred within 7 to 10 days at 
which point the final dimensions of the tablet were measured with a digital caliper 
(Model CO 030150, Marathon).  
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4.1.3 Data Analysis 
4.1.3.1 SRSfactor 
 Multi-component characterization was performed using the replicate 
measurements for each of the three parameters presented in Chapter 3: 
1. Indentation Creep SRS Exponent (n = 15) 
2. ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 (n = 6)  
3. Heckel Based SRS Index (n = 3) 
 The numerical determination of 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 was performed using a two-step 
calculation. First, raw data for each parameter were min-max normalized according to 
Eq. (29): 
 
 𝑧𝑖 =
𝑥𝑖−min (𝑥)
max(𝑥)−min (𝑥)
 (29) 
 
where 𝑥 = (𝑥1, … , 𝑥𝑛) and 𝑧𝑖 was now the 𝑖
𝑡ℎ normalized value. Second, the normalized 
values for each material were averaged using Eq. (30): 
 
 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 =
(𝑧𝑖+,…,+𝑧𝑛)
3
 (30) 
 
 By convention larger values of 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 will be observed for individual 
components and mixtures whose behavior is predominantly viscoplastic and/or 
viscoelastic. The error reported for 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 was determined by propagating the percent 
uncertainty for each parameter. 
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4.2 Results and Discussion 
4.2.1 Raw Material Characterization 
 Summarized data for powder true density and moisture content for all fifteen 
mixtures is provided in Table 18.  
 
Table 18. Mixture true density and moisture content values 
Formulation’s Primary Ingredients (% w/w) True density  % Moisturea (S.D.) 
 
Lycatab® PGS (75 %) : Starch 1500® (25 %) 1.467 (0.003) 8.412 (0.080) 
 
Lycatab® PGS (75 %) : Avicel® PH 200® (25 %) 1.481 (0.004) 7.713 (0.066) 
 
Lycatab® PGS (75 %) : lactose 316 (25 %) 1.477 (0.004) 6.216 (0.059) 
 
Lycatab® PGS (75 %) : anhydrous lactose (25 %) 1.481 (0.002) 6.137 (0.103) 
 
Lycatab® PGS (75 %) : Emcompress® (25 %) 1.669 (0.005) 7.089 (0.114) 
 
Lycatab® PGS (50 %) : Starch 1500® (50 %) 1.476 (0.002) 8.447 (0.238) 
 
Lycatab® PGS (50 %) : Avicel® PH 200® (50 %) 1.504 (0.003) 7.040 (0.061) 
 
Lycatab® PGS (50 %) : lactose 316 (50 %) 1.495 (0.004) 4.384 (0.091) 
 
Lycatab® PGS (50 %) : anhydrous lactose (50 %) 1.503 (0.003) 4.249 (0.101) 
 
Lycatab® PGS (50 %) : Emcompress® (50 %) 1.880 (0.002) 5.769 (0.048) 
 
Lycatab® PGS (25 %) : Starch 1500® (75 %) 1.484 (0.002) 8.469 (0.076) 
 
Lycatab® PGS (25 %) : Avicel® PH 200® (75 %) 1.527 (0.005) 6.349 (0.153) 
 
Lycatab® PGS (25 %) : lactose 316 (75 %) 1.513 (0.004) 2.087 (0.059) 
 
Lycatab® PGS (25 %) : anhydrous lactose (75 %) 1.526 (0.003) 1.876 (0.147) 
 
Lycatab® PGS (25 %) : Emcompress® (75 %) 
 
2.090 (0.006) 4.381 (0.181) 
a Loss on drying 
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 True density values were determined from the true density of the individual 
powder materials. The percentages provided for each component in Table 18 represent 
the weight fraction of each component, which together comprise 96 % of the formulation. 
The remaining 4 % contains a binder, glidant, and lubricant (Table 3). Compaction 
pressures and average out-of-die porosity for each mixture are reported in Table 19.  
 
Table 19. Mixture out-of-die porosity values (0.04 mm/s) 
Mixture 
Compaction 
Pressure (MPa) 
Out-of-die 
Porosity (S.D.) 
 
Lycatab® PGS (75 %) : Starch 1500® (25 %) 165.0 0.820 (0.001) 
 
Lycatab® PGS (75 %) : Avicel® PH 200® (25 %) 136.4 0.819 (0.004) 
 
Lycatab® PGS (75 %) : lactose 316 (25 %) 166.5 0.814 (0.002) 
 
Lycatab® PGS (75 %) : anhydrous lactose (25 %) 160.5 0.820 (0.004) 
 
Lycatab® PGS (75 %) : Emcompress® (25 %) 263.7 0.786 (0.001) 
 
Lycatab® PGS (50 %) : Starch 1500® (50 %) 190.6 0.814 (0.001) 
 
Lycatab® PGS (50 %) : Avicel® PH 200® (50 %) 127.3 0.817 (0.001) 
 
Lycatab® PGS (50 %) : lactose 316 (50 %) 188.3 0.815 (0.001) 
 
Lycatab® PGS (50 %) : anhydrous lactose (50 %) 142.4 0.819 (0.003) 
 
Lycatab® PGS (50 %) : Emcompress® (50 %) 263.7 0.783 (0.004) 
 
Lycatab® PGS (25 %) : Starch 1500® (75 %) 162.0 0.813 (0.001) 
 
Lycatab® PGS (25 %) : Avicel® PH 200® (75 %) 100.2 0.818 (0.002) 
 
Lycatab® PGS (25 %) : lactose 316 (75 %) 130.3 0.813 (0.005) 
 
Lycatab® PGS (25 %) : anhydrous lactose (75 %) 104.0 0.808 (0.002) 
 
Lycatab® PGS (25 %) : Emcompress® (75 %) 
 
263.7 
 
0.787 (0.002) 
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4.2.2 SRSfactor : Individual Components 
 The unscaled values for each of the three parameters used to determine the 
composite factor, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, were collected according to the methods presented in detail 
in Chapter 3. Table 20, below, provides a summary of the average and standard deviation 
of each parameter based on the replicates listed in Section 4.1.3.1.  
   
Table 20. Individual component raw data average and standard deviation values 
Material 
Indentation 
Creep SRS 
Exponent 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
Heckel-Based 
SRS Index 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
0.052 (0.006) 
 
0.120 (0.004) 
 
13.5 (3.4) 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 
 
0.039 (0.003) 
 
0.073 (0.005) 
 
23.6 (2.5) 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.028 (0.002) 
 
0.017 (0.005) 
 
9.6 (4.0) 
 
anhydrous lactose 120 MS 
 
0.026 (0.003) 
 
0.001 (0.002) 
 
3.4 (2.2) 
 
Spray-dried lactose 316 Grade 
 
0.019 (0.002) 
 
0.013 (0.005) 
 
7.1 (3.5) 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
0.016 (0.002) 
 
0.001 (0.002) 
 
0.0 (0.0) 
 
 
 Unscaled values were min/max scaled according to Eq. (29). This transforms the 
data such that the material with the largest experimental value for that parameter assumes 
a scaled value of 1. Conversely, the scaling will also transform the unscaled value of the 
material with the lowest experimental value for that parameter to a scaled value of 0. The 
mix/max scaled values for the data presented in Table 20 is provided in Table 21.  
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Table 21. Individual component min/max scaled values used to compute 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 
Material 
Indentation 
Creep SRS 
Exponent 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
Heckel-
Based SRS 
Index 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
 
1.00 
 
1.00 
 
0.57 
 
Partially pre-gelatinized 
corn starch (Starch 1500®) 
 
0.64 
 
0.61 
 
1.00 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.33 
 
0.14 
 
0.41 
 
anhydrous lactose 120 MS 
 
0.28 
 
0.00 
 
0.15 
 
Spray-dried lactose 316 
Grade 
 
0.08 
 
0.11 
 
0.30 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
0.00 
 
0.00 
 
0.00 
 
 
 The scaled value range will be 0 – 1 regardless of how wide or narrow the range 
is for the unscaled data. For example, if the unscaled data values have a very narrow 
range, the smallest and largest values will appear to be much different numerically after 
being scaled to 0 and 1, respectively. For this reason, it was crucially important to select 
materials that appropriately spanned the range of expected unscaled data values for each 
parameter. With respect to strain rate sensitivity, it was important to use materials whose 
deformation behavior ranged from purely brittle, to highly plastic and/or viscoelastic. As 
a result, differences in each parameter (i.e. speed sensitivity) are related to the mechanical 
properties of each material. Given the selected materials, it is thought that the unscaled 
data value ranges represent the entirety of the range that would be expected for 
pharmaceutical materials with minimum and maximum observed strain rate sensitivity.  
 113 
 The following figure (Figure 45) presents the compiled data for each of the six 
individual components tested. A stacked column plot is used to represent the contribution 
of each parameter to the overall strain rate sensitivity factor, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟. The figure legend 
identifies the color designation that corresponds to each measured parameter. Stacked 
column data for parameters that are not visible indicate the lowest unscaled value for the 
corresponding parameter.  
 
 
Figure 45. Contribution of scaled parameters: Indentation Creep SRS Exponent (  ), 
ΔSFfinal (  ), and Heckel-based SRS Index (  ) values for each individual component. Data 
labels represent the average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value for each material 
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materials that consolidate by fragmentation (lactose grades and Emcompress®) according 
to the rank ordered 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values listed in Figure 45. The composite parameter, 
𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, is valuable for comparing the overall strain rate sensitivity of each material. 
This parameter provides a quantitative measure of how sensitive a material is to changes 
in tablet press speed. For example, Starch 1500® which has an average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value of 
0.75 is much more strain rate sensitive than lactose 316 which only has an average 
𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value of 0.16. In practice, these 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values can be used to understand 
which material is more susceptible to potential changes in deformation behavior upon 
scale-up. Starch 1500® is highly sensitive, so it shouldn’t be unexpected to observe 
deformation behavior changes resulting from changes in the tablet press speed used to 
prepare tablets. Conversely, lactose 316 is generally insensitive and would be expected to 
exhibit nearly identical behavior at both slow and fast compression speed.  
 Another benefit of this analysis is the ability to obtain specific information about 
a material’s strain rate sensitive behavior by looking at the scaled values of each 
individual parameter. The quantitative contribution of each deformation behavior to the 
overall strain rate sensitivity was assessed by taking the ratio of the min/max scaled 
values for the Indentation Creep SRS Exponent and ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙, respectively (Table 22, on 
the following page). 
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Table 22. Contribution of individual deformation behaviors to overall strain rate 
sensitivity of each individual component 
Material 
Indentation 
Creep SRS 
Exponent 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 Ratio 
 
Pre-gelatinized maize starch 
(Lycatab® PGS) 
 
1.00 
 
1.00 
 
1.00 
 
Partially pre-gelatinized corn 
starch (Starch 1500®) 
 
0.64 
 
0.61 
 
1.05 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
 
0.33 
 
0.14 
 
2.35 
 
anhydrous lactose 120 MS 
 
0.28 
 
0.00 
 
-- 
 
Spray-dried lactose 316 Grade 
 
0.08 
 
0.11 
 
0.77 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
0.00 
 
0.00 
 
-- 
 
 
 In cases where a material is insensitive examination of the individual behaviors 
isn’t of that much value. However, in the case where a material shows some sensitivity, 
the individual parameter data can identify the contributing behavior, or behaviors. 
Relative sensitivity of these materials can be understood in terms of their viscoplasticity 
and viscoelasticity, considered separately.  
 Clearly, the deformation behavior of Emcompress® was not affected by changes 
to tablet press speed. In the lab-scale data, Emcompress® behaved similarly regardless of 
the speed used to compact each tablet. This was confirmed by the identical in-die mean 
yield pressures (Heckel-Based SRS Index) for this material at slow and fast speed. 
Emcompress® also showed essentially no viscoelastic recovery, and minimal creep 
displacement as indicated by having the smallest unscaled Indentation Creep SRS 
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Exponent (Table 20). The ability to dissipate applied stress occurs rapidly for a material 
like Emcompress® that cracks and breaks. 
 Sensitivity that was observed for Avicel® PH 200 appears to be due to its time-
dependent plasticity with little contribution from its viscoelastic behavior. This was 
confirmed by the data presented in Table 22. Avicel® PH200 had a ratio of 2.35 when 
comparing its viscoplastic sensitivity to its viscoelastic sensitivity. Ratio values much 
greater than one indicate that viscoplastic behavior is the dominating time-dependent 
deformation mechanism. It was hypothesized that this phenomenon is due, in part, to the 
high percentage of intra-particle porosity reported for this material [48]. Agglomerated 
microcrystalline cellulose like Avicel® PH 200 can permanently deform on both the 
macro and micro scales [116]. Macroscopically the intra-particle pore structure can 
collapse, while dislocation due to the presence of slip planes in the crystalline lattice will 
induce permanent deformation on the microscale [117]. Both mechanisms contribute to 
the observed plasticity of this material. Lab-scale data collected for this material suggests 
that only a fraction of the observed plasticity is time-dependent. This was confirmed by 
comparing the Out-of-die Heckel Slope to the Indentation Creep SRS Exponent for this 
material (Section 3.2.2). The collapse of the intra-particulate pore structure results in a 
reduction in porosity. Particles are not fractured or broken, but deform as the entrapped 
air is released. It is reasonable to suspect that the collapse of the intra-particulate pore 
structure occurs rapidly compared to the time required to induce dislocation movement. 
As a result, Avicel® PH 200 will deform significantly during compression on both the 
macro and micro scale, but only a fraction of that deformation will be time-dependent.   
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 For Lycatab® PGS, its plasticity was speed dependent, but its elasticity was also 
highly sensitive. This was quantitatively assessed by looking at the ratio of viscoplasticity 
(Indentation Creep SRS Exponent) to viscoelasticity (∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙) in Table 22. The ratio for 
Lycatab® PGS was unity, confirming that both deformation modes contribute equally to 
the observed strain rate sensitivity of that material. Starch is a carbohydrate that consists 
of two different types of glucose polysaccharides, namely amylose and amylopectin. It is 
hypothesized that the viscoelasticity of this material is due to the chemical structure of 
these two units. Amylose is starch formed by unbranched chains of glucose monomers, 
whereas amylopectin is a branched polysaccharide. Because of the way the subunits are 
joined, glucose chains assume a helical structure [118]. Therefore, it was hypothesized 
that this structure is able to compress like a spring when subjected to an applied load. 
Stresses are stored but not dissipated. As a result, a large portion of this materials 
deformation is reversible. Upon ejection from the die, the stored elastic strain is 
recovered leading to its high degree of viscoelasticity.  
 Beyond specific information about the sensitivity of each deformation mode, the 
practical implications of strain rate sensitivity are of great importance to formulators and 
process development scientists. In the case of an insensitive and brittle material like 
Emcompress®, no changes to deformation behavior would be predicted under high-speed 
compaction conditions. The same cannot be said for Lycatab® PGS. Lycatab® PGS 
showed differences in its deformation behavior with speed. Tablets prepared under high-
speed conditions will likely exhibit reduced strength when compared to tablets of the 
same material prepared under slower speed conditions. In cases where large differences 
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are observed, problems such as excessive friability and absence of pharmaceutical 
elegance may result from a mechanically weak tablet product.  
 
4.2.3 SRSfactor : Mixtures 
 Overall strain rate sensitivity values (𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟) for each of the fifteen mixtures 
are provided in Figure 46. Data points are grouped according to the percentage of 
Lycatab® PGS in each mixture. Individual component data are provided as a reference. 
   
 
Figure 46. SRSfactor values for each mixture in combination with Lycatab
® PGS 
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compound to simulate the presence of a strain rate sensitive active ingredient in 
combination with excipients expressing varied deformation behavior. In order to vary the 
strain rate sensitivity of each mixture, the amount of Lycatab® PGS was progressively 
decreased from 75 % to 25 % as indicated in Figure 46.  
 In general, as the percentage of Lycatab® PGS in each mixture decreased, so did 
the measured strain rate sensitivity. How much the sensitivity changed was dependent on 
the sensitivity of the other excipient in the mixture. At 75 % Lycatab® PGS in the 
mixture, the largest reduction in overall strain rate sensitivity was observed for the 
mixture containing the least sensitive material on its own, Emcompress®. The 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 
decreased from 0.86 for Lycatab® PGS by itself, to 0.52 for the mixture containing 25 % 
Emcompress®. In comparison, the other mixtures at that same ratio had average 
𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values that ranged from 0.60 - 0.66 and were not statistically insignificant from 
one another. For these mixture combinations, it was apparent that strain rate sensitivity 
was most affectively mitigated by including another component that was not strain rate 
sensitive. All average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values for the mixtures containing Emcompress
® were 
less than the average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values for any of the other mixture combinations. 
Discussions regarding atypical mixture behavior are provided for each combination of 
excipient with Lycatab® PGS. Information related to the specific deformation behaviors 
that contribute to the observed sensitivity will be discussed.  
 
4.2.3.1 Lycatab® PGS : Starch 1500® Mixtures 
 The first set of mixtures that were analyzed contained two highly strain rate 
sensitive materials based on their average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟  values. Lycatab
® PGS was the most 
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sensitive, having an average value of 0.86 while Starch 1500® had an average measured 
value of 0.75 (Figure 45). A t-test comparing group means indicated that no statistically 
significant difference between values was observed. Therefore, it was confirmed 
quantitatively that these two materials had equivalent overall strain rate sensitivity.  
 Summarized mixture behavior is provided in Figure 47. Plotted on the primary y-
axis are the scaled values for each of the three individual parameters. The secondary y-
axis represents the average of these three scaled values, or the composite parameter 
𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟. Columns were grouped and labeled according to the weight percentage of 
Lycatab® PGS in the mixture. The individual component data is provided for reference.    
 
 
Figure 47. Scaled parameters: Indentation Creep SRS Exponent (  ), ΔSFfinal (  ), Heckel-
based SRS Index (  ) and average SRSfactor (-□-) values for Lycatab® PGS : Starch 1500® 
mixtures 
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 The 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value at a composition of 75 % Lycatab
® PGS : 25 % Starch 1500® 
decreased significantly compared to the 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟  value of Lycatab
® PGS alone. The 
remaining mixtures (50 % Lycatab® PGS : 50 % Starch 1500® and 25 % Lycatab® PGS : 
75 % Starch 1500®) maintained a fairly constant sensitivity across all compositions. No 
statistically significant differences in average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟  values for those mixtures were 
observed when compared to the individual component values.  
 Mixture behavior in the literature has largely been categorized as being either 
ideal or non-ideal. Ideal mixtures follow a simple arithmetic relationship with respect to 
the mixture composition. In other words, when the deformation properties of a mixture’s 
components contribute to the overall behavior strictly according to their weight 
proportions in the mixture, it would be classified as ideal mixing behavior. Many reports 
of ideal behavior have been reported previously [78,119-123]. Non-ideal behavior is 
observed in mixtures that behave either more or less similarly to one component than 
would be predicted from the behavior of both components. This behavior is identified as 
having either positive or negative deviations from linearity [123-127]. 
 Lycatab® PGS : Starch 1500® mixtures showed both positive and negative 
deviations depending on the mixture composition (Figure 48, on the following page). 
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Figure 48. SRSfactor values for Lycatab
® PGS : Starch 1500® mixtures (- ◊ -). Linear 
mixture model data (◊) is provided 
 
 Except for the 50 : 50 mixture, the 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values could not be predicted from 
the properties of the individual constituents. For example, the predicted 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value 
based on the linear mixture model for the mixture containing 75 % Lycatab® PGS was 
0.83 compared to the measured value of 0.68. Differences in sensitivity that were 
observed for each mixture appear to be influenced primarily by the viscoelastic 
component of their behavior. This was confirmed by comparing the mixture data for the 
Indentation Creep SRS Exponent and ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙. The unscaled values for both of these 
parameters are provided in Table 23 along with their standard deviations based on the 
replicates listed for each measurement in Section 4.1.3.1. 
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Table 23. Lycatab® PGS : Starch 1500® mixture unscaled parameter values 
Mixture Composition 
Indentation Creep  
SRS Exponent (S.D.) 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 (S.D.) 
 
Lycatab® PGS (75 %) : 
Starch 1500® (25 %) 0.042 (0.003) 0.092 (0.004) 
 
Lycatab® PGS (50 %) : 
Starch 1500® (50 %) 0.041 (0.002) 0.112 (0.004) 
 
Lycatab® PGS (25 %) : 
Starch 1500® (75 %) 
 
0.042 (0.003) 
 
0.108 (0.004) 
 
 
 Each mixture appears to have very similar strain rate sensitivity based on the 
creep data, but are different in terms of the ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙  results. The viscoelastic response is 
more affected by strain rate in the mixtures with 25 % and 50 % Lycatab® PGS than it is 
in the mixture with 75 %. The difference in viscoelasticity of these mixtures is manifest 
in the relaxation of the tablets. The mixtures with 25 and 50 % Lycatab® PGS expanded 
to a greater extent than the mixture with 75 % Lycatab® PGS as represented by the 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values in Table 23.  
 
4.2.3.2 Lycatab® PGS : Avicel® PH200 Mixtures 
 The next set of mixtures contained Avicel® PH 200, a material that has been 
shown in this work to be sensitive primarily due to its viscoplastic deformation behavior. 
Figure 49, on the following page, provides the compiled data for each of these three 
mixtures. Again, individual component data have been provided for reference. 
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Figure 49. Scaled parameters: Indentation Creep SRS Exponent (  ), ΔSFfinal (  ), Heckel-
based SRS Index (  ) and average SRSfactor (-□-) values for Lycatab® PGS : Avicel® PH 
200 mixtures 
 
 Mixtures of the most sensitive individual component, Lycatab® PGS, with a 
highly plastic material, Avicel® PH 200 showed strain rate sensitivities intermediate to 
the sensitivity of each individual component. A reduction in sensitivity was not 
unexpected as the amount of Avicel® PH 200 in the mixture increased given the 
difference in sensitivity of the individual components. 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values were 
approximated using a linear mixture model and the strain rate sensitivities of each 
individual component. Quality of fit was assessed by comparing the measured and 
predicted values (Table 24). 
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Table 24. Lycatab® PGS : Avicel® PH200 mixtures scaled and predicted  𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 
values 
Mixture Composition 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 
Predicted 
𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 
Residual 
 
Lycatab® PGS 0.86 0.86 -- 
 
Lycatab® PGS (75 %) : 
Avicel® PH200 (25 %) 0.64 0.72 -0.08 
 
Lycatab® PGS (50 %) : 
Avicel® PH200 (50 %) 0.56 0.57 -0.01 
 
Lycatab® PGS (25 %) : 
Avicel® PH200 (75 %) 
 
0.38 
 
0.43 
 
-0.05 
 
 
Avicel® PH200 
 
0.29 
 
0.29 
 
-- 
 
 
 For all the mixtures, the predicted 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values were greater than the 
experimental values. In order, the differences were -0.08 for the mixture containing 75 % 
Lycatab® PGS, followed by -0.01 for the 50 : 50 mixture, and -0.05 for the mixture with 
the most Avicel® PH200. Negative residuals for all mixtures indicate a slight negative 
deviation. It is presumed that this behavior is due to the consistency in the trend of the 
individual parameters used to determine 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟.  
 The contribution of viscoplasticity and viscoelasticity appear to be the same for 
the mixtures containing 75 % and 50 % Lycatab® PGS, but slightly different from the 
mixture containing 25 % as presented in Figure 50, on the following page.  
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Figure 50. Scaled parameters: Indentation Creep SRS Exponent (  ) and ΔSFfinal (  ) for 
the three Lycatab® PGS : Avicel® PH 200 mixtures 
 
 In addition to plasticity being time-dependent for these mixtures, the viscoelastic 
component of their behavior was also a contributing factor. Based on the scaled values, 
viscoelasticity contributed nearly equivalently for the mixtures containing 75 % and 50 % 
Lycatab® PGS. The ratio of viscoplasticity to viscoelasticity was 1.02 and 0.98, 
respectively. As before, values close to unity indicate nearly equivalent contribution from 
both behaviors to the observed sensitivity. The mixture containing only 25 % Lycatab® 
PGS showed sensitivity dependent more on viscoplastic behavior in the absence of 
sensitivity of the viscoelastic mode (Figure 50). This mixture exhibited behavior that 
favored the more abundant component in the mixture. This can be confirmed by 
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examining the trends for that mixture and Avicel® PH200 as an individual component in 
presented previously in Figure 49.  
 
4.2.3.3 Lycatab® PGS : lactose 316 Mixtures 
 The third set of mixtures contained lactose 316 in combination with Lycatab® 
PGS. This mixture combination can be used to evaluate the behavior of a highly sensitive 
component with a material that had minimal observed sensitivity (Figure 46). The 
compiled data for each of these mixtures is provided in Figure 51, below. Individual 
component data has been provided for comparison. 
 
 
Figure 51. Scaled parameters: Indentation Creep SRS Exponent (  ), ΔSFfinal (  ), Heckel-
based SRS Index (  ) and average SRSfactor (-□-) values for Lycatab® PGS : lactose 316 
mixtures 
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 A reduction in overall strain rate sensitivity of each mixture was not unexpected 
given the large difference in strain rate sensitivity of each individual component. The 
mixture containing 25 % Lycatab® PGS had an average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟  value of 0.38 which 
was significantly less than the average 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value for the mixture containing 75 % 
Lycatab® PGS which was computed to be 0.64. The behavior of 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 was 
accurately predicted by the same linear mixing model applied to the mixtures of Lycatab® 
PGS with Starch 1500® and Avicel® PH200 shown in Figure 52. 
 
 
Figure 52. SRSfactor values for Lycatab
® PGS : lactose 316 mixtures (- ◊ -). Linear mixture 
model data (◊) is provided 
 
 The largest difference between the actual and predicted values was 0.05 for the 
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residual differences were less than the uncertainty in the measured 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values. 
Although the overall risk factor exhibited ideal behavior, it was interesting to observe that 
some of individual parameters did not (Figure 51). The most noticeable deviation was 
observed for the parameters evaluating viscoelasticity, ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙. The unscaled ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
values for each mixture are provided in Table 25, below. The predicted values were 
calculated based on the linear combination of each component in the mixture.  
  
Table 25. Lycatab® PGS : lactose 316 mixture unscaled and predicted ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values 
Mixture ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 (S.D.) 
Predicted
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
Residual 
 
Lycatab® PGS 0.120 (0.004)  0.120 
 
-- 
 
Lycatab® PGS (75 %) : 
lactose 316 (25 %) 0.095 (0.005) 0.093 
 
 
0.002 
 
Lycatab® PGS (50 %) : 
lactose 316 (50 %) 0.093 (0.005) 0.067 
 
 
0.026 
 
Lycatab® PGS (25 %) : 
lactose 316 (75 %) 
 
0.043 (0.010) 
 
0.040 
 
 
0.003 
lactose 316 
 
 
0.013 (0.005) 
 
0.013 
 
-- 
 
 For all mixtures, the viscoelastic recovery was greater than would be predicted 
based on the behaviors of the components. This is confirmed by positive residual values 
for each mixture. The largest residual was observed for the mixture containing 50 % 
Lycatab® PGS. A linear mixture model under predicted solid fraction by a value of 0.026 
or ~ 28 %. It has been reported previously that softer materials can have a greater effect 
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on the deformation behavior observed in mixtures than more rigid components [128,129]. 
The behavior has been attributed to a particulate-level effect, where the softer particles 
deform preferentially and dominate the overall behavior. This would cause the softer 
material to contribute more to the overall behavior than its weight fraction would 
indicate. In this case, the softer material in the mixture is Lycatab® PGS which has a 
hardness value at the start of the hold region of 12.3 MPa compared to a hardness value 
under the same experimental conditions of 35.8 MPa for lactose 316. Although this 
rational seems reasonable, the effect appears to be only applicable to the 50 : 50 mixture 
since the residuals for the other mixtures are less than the uncertainty of the unscaled 
values. 
 
4.2.3.4 Lycatab® PGS : anhydrous lactose Mixtures 
 An additional lactose grade was evaluated in mixtures with Lycatab® PGS at the 
same compositions as each of the previous three materials. Mixtures of Lycatab® PGS 
with anhydrous lactose exhibited overall strain rate sensitivity behavior intermediate to 
the behavior of the individual components. Figure 53, on the following page, provides a 
plot of the composite strain rate sensitivity parameter, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, overlaid with the linear 
mixture model predictions based on weight composition in the mixture. Individual 
component and mixture 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values are listed as data labels for reference.  
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Figure 53. SRSfactor values for Lycatab
® PGS : anhydrous lactose mixtures (- ◊ -). Linear 
mixture model data (◊) is provided 
 
 The presence of a brittle material in the mixture effectively reduced the overall 
strain rate sensitivity, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, progressively from 0.66 for the mixture containing 75 % 
Lycatab® PGS to 0.42 for the mixture containing 50 % Lycatab® PGS. The reduction in 
sensitivity for these mixtures corresponded favorably with the predicted behavior based 
on the contribution of each constituent. However, as the amount of Lycatab® PGS in the 
mixture was decreased to 25 %, atypical behavior was observed. For the mixture 
containing 25 % Lycatab® PGS, no reduction in sensitivity was measured even though an 
additional 25 % of a non-sensitive material was added to the mixture. The nearly 
identical behavior of these two mixtures can be understood by comparing the scaled 
values of each of the three parameters used to determine 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟.  
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 Figure 54 provides the compiled data for each mixture of anhydrous lactose in 
combination with Lycatab® PGS. The parameters corresponding to viscoplastic, 
viscoelastic, and non-descriptive time-dependent deformation behavior are labeled 
accordingly.  
 
 
Figure 54. Scaled parameters: Indentation Creep SRS Exponent (  ), ΔSFfinal (  ), and the 
Heckel-based SRS Index (  ) for Lycatab® PGS : anhydrous lactose mixtures 
 
 As mentioned, for the mixtures containing 50 % and 25 % Lycatab® PGS, no 
change to the strain rate sensitivity was measured. This is confirmed by the identical 
average values for the Indentation Creep SRS Exponent (0.61) and ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 (0.27). As a 
result, the corresponding ratio of those two parameters is also identical meaning that the 
contribution of viscoplastic to viscoelastic behavior is the same. In both mixtures, the 
dominating mechanism of the observed sensitivity was viscoplasticity. The ratio of the 
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Indentation Creep SRS Exponent to ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 was 2.26. Compared to the mixture 
containing 75 % Lycatab® PGS, which had a ratio of the same parameters equal to 1.14, 
viscoelastic behavior contributed to a much lesser extent. The only difference observed 
for these two mixtures was in the Heckel-Based SRS Index. A slight reduction in the 
average value from 0.38 to 0.34 was measured as the amount of Lycatab® PGS in the 
mixture decreased from 50 to 25 %.  
 From a formulation prospective, the behavior of these two mixtures is compelling. 
anhydrous lactose is able to accommodate an additional 25 % w/w of a highly sensitive 
material to its formulation with no changes to its sensitivity. For most of the other 
excipients in combination with Lycatab® PGS, there was an decrease in the strain rate 
sensitivity of the mixture as the amount of Lycatab® PGS decreased (Figure 46). The 
Starch 1500® mixtures were the exception, but the high strain rate sensitivity of those 
mixtures make them high risk when considering scale-up operations. The ability of 
anhydrous lactose to mitigate sensitivity in this manner is particularly valuable. For 
example, in instances where the drug load is high and/or the active is highly sensitive like 
Lycatab® PGS, anhydrous lactose can be used to mitigate sensitivity even when the 
sensitive material is present in relatively large amounts.  
 
4.2.3.5 Lycatab® PGS : Emcompress® Mixtures 
 The final material that was mixed in combination with Lycatab® PGS was 
Emcompress®. Experimentally, Emcompress® tested as the least sensitive individual 
component of the six materials under investigation. As a result, these mixtures represent 
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the combinations of the most sensitive material with the least sensitive material. Figure 
55 presents the compiled data for Emcompress® in combination with Lycatab® PGS.  
 
 
Figure 55. Scaled parameters: Indentation Creep SRS Exponent (  ), ΔSFfinal (  ), Heckel-
based SRS Index (  ) and average SRSfactor (-□-) values for Lycatab® PGS : Emcompress® 
mixtures 
 
 The two materials principally consolidate by different mechanisms: Lycatab® 
PGS is plastic and viscoelastic and Emcompress® is highly brittle. As a result, the overall 
strain rate sensitivity, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, of mixtures of these two materials were intermediate to 
the sensitivity of each individual component. It was observed that the largest reduction 
occurred for the mixture containing 25 % Emcompress® relative to the sensitivity of 
Lycatab® PGS alone. The 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 value decreased from 0.86 to 0.52. Further 
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reductions in strain rate sensitivity were observed for the remaining two mixtures, but to 
a lesser extent. For example, the change in 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 between the mixture containing 75 
% Lycatab® PGS and the mixture containing 50 % Lycatab® PGS was 0.15. These 
reductions were not unexpected given the large difference in strain rate sensitivity of each 
individual component. More specific interpretations about the strain rate sensitivities of 
these mixtures can be gained by looking at the values of the three individual parameters 
used to calculate 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟.  
 It was observed that Heckel-Based SRS Index values were under predicted for 
two of the three mixtures based on the composition of each component. The effect was 
particularly noticeable in the mixture containing 75 % Lycatab® PGS. The unscaled 
Heckel-Based SRS Index values for each mixture are provided in Table 26, below.  
  
Table 26. Lycatab® PGS : Emcompress® mixture unscaled and predicted Heckel-Based 
SRS Index values 
Mixture 
Heckel-Based 
SRS Index 
(S.D.) 
Predicted 
Heckel-Based 
SRS Index 
Residual 
 
Lycatab® PGS 13.5 (3.4)  13.5 
 
-- 
 
Lycatab® PGS (75 %) : 
Emcompress® (25 %) 4.8 (2.6) 10.1 
 
 
-5.3 
 
Lycatab® PGS (50 %) : 
Emcompress® (50 %) 4.5 (2.7) 6.8 
 
 
-2.3 
 
Lycatab® PGS (25 %) : 
Emcompress® (75 %) 
 
3.5 (3.0) 
 
3.4 
 
 
0.1 
Emcompress® 
 
 
-- 
 
-- 
 
-- 
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 Negative residuals indicate that the mixture was behaving more like the individual 
component with the lower Heckel-Based SRS Index value. Based on that parameter, 
alone, these mixtures would be classified as having limited strain rate sensitivity. For 
example, the Heckel-Based SRS Index values for these mixtures compares favorably to 
the same parameter value for anhydrous lactose as an individual component (Table 20).  
 However, when considering the strain rate sensitivity based on all three 
parameters, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 values were greater than the Heckel-Based SRS Index. This 
difference appears to be due to the viscoelastic behavior. Table 27 lists the unscaled 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values for each individual component and their corresponding mixture. 
Predicted values are based on a linear mixing rule. 
 
Table 27. Lycatab® PGS : Emcompress® mixture unscaled and predicted ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 values 
Mixture ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 (S.D.) 
Predicted 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 
Residual 
 
Lycatab® PGS 0.120 (0.004)  0.120 
 
-- 
 
Lycatab® PGS (75 %) : 
Emcompress® (25 %) 0.098 (0.004) 0.090 
 
 
0.008 
 
Lycatab® PGS (50 %) : 
Emcompress® (50 %)  0.077 (0.005) 0.061 
 
 
0.016 
 
Lycatab® PGS (25 %) : 
Emcompress® (75 %) 
 
0.052 (0.004) 
 
0.031 
 
 
0.021 
Emcompress® 
 
 
0.001 (0.002) 
 
-- 
 
-- 
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 The positive residuals for all three mixtures indicate an under prediction of 
∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙 based on the data collected for each individual component. These data offset the 
negative deviations observed in the Heckel-Based SRS Index data provided in Table 26. 
Post-ejection from the die, mixtures show viscoelastic recovery that was dominated much 
more so by Lycatab® PGS than it was by Emcompress®. For the combination of Lycatab® 
PGS with Emcompress® both constituents dominate the behavior of the mixtures, albeit 
differently. 
 
4.3 Summary 
 A multi-dimensional parameter was used to identify the specific mechanical 
behavior/s responsible for a material’s observed strain rate sensitivity. The strain rate 
sensitive deformation behavior of six pharmaceutical excipients and fifteen mixtures was 
analyzed. Individual component sensitivity was rank-ordered from the most to the least 
sensitive. A detailed description of a materials time-dependent deformation behavior can 
be described in terms of plasticity and elasticity, considered independently (Table 28, on 
the following page).      
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Table 28. Individual component strain rate sensitivity summary 
Individual Component 
Strain Rate Sensitivity 
(𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟) 
Contributing Deformation Behavior/s 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
High 
(0.86) Viscoplasticity, Viscoelasticity 
 
Partially pre-gelatinized 
corn starch (Starch 1500®) 
High 
(0.75) Viscoplasticity, Viscoelasticity 
 
Microcrystalline cellulose 
(Avicel® PH 200) 
Intermediate 
(0.29) Viscoplasticity 
 
Spray-dried lactose 316 
Grade 
Low 
(0.16) -- 
 
 
anhydrous lactose 120 MS 
Low 
(0.14) -- 
 
Dibasic calcium phosphate 
dihydrate (Emcompress®) 
 
Low 
(0.00) 
 
-- 
 
 
 Mixture behavior was assessed by changing the composition of the most sensitive 
individual component (Lycatab® PGS) in combination with five other excipients. The 
largest reduction in overall strain rate sensitivity, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟, of a mixture was observed 
when the second component in the mixture was highly brittle (i.e., Lycatab® PGS mixed 
with Emcompress®). The extent of reduction was dependent on the difference in strain 
rate sensitivity of each individual component. The further apart they were, the larger the 
reduction. Conversely, combining two viscoplastic/viscoelastic materials did little to 
mitigate the sensitivity of Lycatab® PGS (i.e., Lycatab® PGS mixed with Starch 1500®). 
 Several interesting mixtures were identified among the fifteen that were tested. 
First, when 75 % Avicel® PH 200 was mixed with 25 % Lycatab® PGS the behavior 
responsible for the observed sensitivity changed relative to the behavior of the other 
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mixture compositions. In that mixture, Lycatab® PGS’s time-dependent elasticity was 
minimized. The behavior was controlled by Avicel® PH 200 and as a result sensitivity 
was primarily due viscoplasticity. Second, are the mixtures of Lycatab® PGS with 50 % 
and 75 % anhydrous lactose. No change to mixture sensitivity was observed when the 
amount of Lycatab® PGS in the mixture was increased from 25 % to 50 %. This 
observation was unique since for all other mixtures, 𝑆𝑅𝑆𝑓𝑎𝑐𝑡𝑜𝑟 increased as the amount of 
Lycatab® PGS in the mixture increased. Anhydrous lactose was able to modulate the 
behavior of Lycatab® PGS up to 50 % in a mixture. Last, the mixtures of Lycatab® PGS 
with Emcompress® exhibited behavior that was dominated by each component, though 
differently. Mixtures showed relative insensitivity to compression speed based on the 
Heckel-Based SRS Index data, but were highly viscoelastic. During compression at two 
different speeds, the brittle component (Emcompress®) controlled consolidation. 
However, post-compression the tablets demonstrated viscoelastic recovery that was 
dominated by the recovery of Lycatab® PGS.  
 This multi-component approach proves valuable for assessing strain rate 
sensitivity. In cases where complicated behavior is observed, this technique can be used 
to identify the specific contributing deformation behaviors. Additionally, this method is 
also material-sparing only requiring gram level quantities of material. If only a small 
amount of raw material is available or where a large number of different materials are to 
be studied, this method allows for a detailed understanding of time-dependent 
deformation behavior to be learned.      
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Chapter 5: Conclusions  
 
 In addition to plastic deformation, the elastic response of a material to stress can 
be time-dependent. Since many pharmaceutical materials also demonstrate relatively 
large amounts of elastic deformation, it can be difficult to identify whether a material’s 
strain rate sensitivity is due to changes in elasticity or due to changes in plasticity at 
different speeds. A characterization method that is specific to individual deformation 
modes would be helpful for improving the understanding of the strain rate sensitivity of 
these materials. As a result, the experimentation presented in this dissertation was 
designed to test the hypothesis that a multi-component, lab-scale assessment of strain rate 
sensitivity enables overall sensitivity to be quantified, and identification of the specific 
mechanical behaviors contributing to the observed sensitivity.   
 The goal of the first specific aim was to establish the effect of compression speed 
on the tableting profiles (compressibility and tabletability) of three common 
pharmaceutical excipients with varied deformation behavior. High speed experiments 
were performed using a Huxley-Bertram compaction simulator. Material compressibility 
and tabletability was assessed. Emcompress® was insensitive to tablet press speed 
changes in both profiles. Avicel® PH200 and Lycatab® PGS both showed sensitivity, but 
that sensitivity was different for the two materials. Insensitivity in these commonly used 
profiles suggests that the compaction behavior of that material is unaffected by changes 
to tablet press speed. In instances where sensitivity is observed, nearly equivalent 
compaction behavior would not be expected as a result of changing the speed of the tablet 
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press. The observed sensitivity was dependent on the predominant deformation behavior 
of the material being studied. 
 The goal of the second specific aim was to introduce three lab-scale 
measurements that comprehensively describe the various aspects of strain rate sensitivity 
during powder compaction. These specific parameters were selected based on the need to 
improve current methods used to characterize strain rate sensitivity, and the complexity 
of time-dependent deformation. Strain rate sensitivity was assessed by combining three 
individual parameters: 1) Indentation Creep SRS Exponent, 2) ΔSFfinal, and 3) Heckel-
Based SRS Index. Materials with the largest experimental values for each of the three 
parameters (Lycatab® PGS and Starch 1500®), deform predominantly by plastic and/or 
viscoelastic mechanisms. Conversely, materials which had the lowest experimental 
values (Emcompress®) are highly brittle. The use of these three parameters, in 
combination, allows for more specific characterization of strain rate sensitivity.  
 Finally, the goal of the third specific aim was to quantify strain rate sensitivity, of 
several common pharmaceutical excipients and mixtures containing those materials, 
using a composite evaluation of time-dependent deformation. For the individual 
components, Lycatab® PGS was the most sensitive and Emcompress® was the least. 
Sensitivity of the materials can be understood in terms of viscoplasticity and 
viscoelasticity, considered separately. For example, any sensitivity that was observed for 
Avicel® PH 200 appears to be due to its time-dependent plasticity with little or no 
contribution from its viscoelastic behavior. For Lycatab® PGS, its plasticity is speed 
dependent, but its elasticity is also highly sensitive.  
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 Mixture behavior was decidedly more complex. In general, strain rate sensitivity 
was reduced when a less sensitive material was added to the mixture. How significant 
that reduction was depended on the difference in strain rate sensitivities of each 
individual component. Of the fifteen mixtures that were analyzed, several stood out. For 
example, for two of the mixtures of Lycatab® PGS with anhydrous lactose no change to 
the mixture strain rate sensitivity was observed. The sensitivity of Lycatab® PGS was 
effectively mitigated as the amount of Lycatab® PGS in the mixture increased from 25 to 
50 %.  
 Based on the data presented in this dissertation, it is evident that the combination 
of factors used to characterize time-dependent deformation allows for a more detailed 
characterization of strain rate sensitivity. Assessing the time-dependency of both 
plasticity and elasticity offers the potential to understand what role each deformation 
behavior plays in the overall sensitivity of a material upon scale-up.  
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Appendix A: Material-Sparing Method for Deriving the Out-of-Die 
Heckel Slope from Data Collected During a Single Compression-
Decompression Cycle  
 
 The purpose of the work described in Appendix A was to demonstrate a 
procedure by which the data collected during a single compression cycle can be used to 
derive out-of-die Heckel data. The data collected form a single compression-
decompression cycle was used to generate a profile equivalent to a complete out-of-die 
compressibility profile that had been corrected for both elastic and viscoelastic recovery. 
 
A.1 Data Correction  
 Unlike in-die Heckel analysis, out-of-die Heckel analysis requires generating a 
larger number of tablets to assess volume reduction behavior over a range of applied 
pressures. Typical in-die (Figure A.1) and out-of-die (Figure A.2) Heckel plots for 
Lycatab® PGS are shown on the following page, respectively. 
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Figure A. 1. In-die Heckel plot for Lycatab® PGS compacted at 0.04 mm/s 
 
Figure A. 2. Out-of-die Heckel plot for Lycatab® PGS compacted at 0.04 mm/s 
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 Although out-of-die Heckel analysis allows researchers to assess the 
consolidation behavior of a powder after elastic and viscoelastic deformation have been 
recovered, this method is time-consuming and requires a significant amount of raw 
material. To take advantage of the benefits of each method, a procedure that uses data 
collected during a single compression-decompression cycle (in-die, Figure A.1) was used 
to generate a profile equivalent to a complete out-of-die Heckel profile (Figure A.2). This 
procedure utilizes corrections to the in-die data for both elastic and viscoelastic recovery 
to generate a corrected Heckel profile that is indistinguishable from data collected using 
the out-of-die approach [114,115].  
 The derivation is based on two simple assumptions. First, the amount of elastic 
recovery that occurs when a powder bed is decompressed from a specific applied 
pressure is equivalent to the change in solid fraction that occurs because of elastic 
deformation during compression up to the sample level of applied pressure, even if the 
pressure of interest is less than the maximum pressure used to compact the tablet. The 
second assumption is that the decrease in solid fraction due to viscoelastic recovery after 
ejection is not significantly dependent on the maximum applied pressure. These two 
assumptions allow correction for elastic recovery using the in-die data collected during 
decompression and correction for viscoelastic recovery using the solid fraction change 
after ejection. 
 Since this correction method relies on in-die data, proper corrections for machine 
part deformation were performed. Methods describing how that correction was performed 
can be referenced in Section 2.1.2.5. Prior to applying the solid fraction correction 
method used to obtain the Out-of-Die Heckel Slope, the raw data was transformed into 
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profiles of pressure (Eq.(16)) versus in-die solid fraction (Eq.(17)). The in-die 
compressibility profiles were acquired from the data recorded during the compression of 
each material at 0.04 mm/s outlined in Section 3.1.2.2.  
 An example in-die solid fraction versus compaction pressure profile for Lycatab® 
PGS prepared at 0.04 mm/s is provided in Figure A.3. 
 
 
Figure A. 3. In-die solid fraction versus pressure profile for Lycatab® PGS compacted at 
0.04 mm/s 
 
 It is assumed that the amount of elastic recovery that occurs upon decompression 
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subtracting the change in solid fraction that occurred during decompression from the 
same pressure. This approach is applied even for pressures that are less than the 
maximum pressure used during the compression cycle. The corrected solid fraction 
(𝑆𝐹𝑐/𝑑) associated with each applied pressure can be determined using Eq. (25): 
 
 𝑆𝐹𝑐/𝑑 = 𝑆𝐹𝑐 − [𝑆𝐹𝑑 − 𝑆𝐹𝑑(0)] (25) 
 
where 𝑆𝐹𝑐 and 𝑆𝐹𝑑 correspond to the solid fraction values measured at the same pressure 
during compression and during decompression, respectively. 𝑆𝐹𝑑(0) represents the solid 
fraction of the compact measured after the applied pressure has returned to zero but has 
not been ejected. This value is calculated using the thickness of the powder bed, in the 
die, at the moment the applied pressure returns to zero and reflects immediate elastic 
recovery in the axial direction but does not include radial elastic recovery or viscoelastic 
recovery.  
 Application of this correction to the pressure range over which in-die 
compressibility data were collected produces a function of elasticity-corrected solid 
fraction as a function of applied pressure (Figure A.4).  
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Figure A. 4. Elasticity corrected solid fraction (•••) versus pressure profile for Lycatab® 
PGS compacted at 0.04 mm/s 
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points in cases where specific pressure values were unique to either the compression or 
decompression phase. Nevertheless, 𝑆𝐹𝑐/𝑑 data were obtained spanning the entire 
pressure range of each profile.  
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separate tablets compressed to maximum pressures of 38 and 264 MPa, respectively 
(Figure A.5).  
 
 
Figure A. 5. Pressure versus displacement profiles for Lycatab® PGS compacted at 0.04 
mm/s. Compression-decompression profiles for tablets compacted to 38 MPa (―) and 
264 MPa (―) are labeled 
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more than 0.002 for all materials. The change in solid fraction due to elastic deformation 
during compression to 38 MPa appears to be the same as the amount of elastic 
deformation recovered during decompression from 38 MPa, even if the maximum applied 
pressure (264 MPa) is substantially higher. The consistency supports the assumption that 
the amount of elastic recovery only depends on the range of pressure considered and not 
on the maximum pressure used to prepare the compact.    
 A second correction was applied to the elasticity corrected in-die data (𝑆𝐹𝑐/𝑑) 
based on the assumption that the extent of viscoelastic recovery post ejection is relatively 
independent of the maximum applied pressure. This assumption allows for the change in 
solid fraction due to viscoelastic recovery after compression to one maximum applied 
pressure (264 MPa) to be used to correct for the time-dependent reversible deformation 
occurring at all other levels of applied pressure. The solid fraction change after ejection, 
referred to as ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙, represents the difference in solid fraction between 𝑆𝐹𝑐/𝑑 and the 
measured out-of-die solid fraction (Figure A.6, following page). 
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Figure A. 6. Viscoelastic recovery versus pressure profile for Lycatab® PGS compacted 
at 0.04 mm/s. Data points represent average values (n = 6) and associated error bars 
represent standard deviation 
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 It should be noted that an applied pressure of 264 MPa is not of intrinsic 
significance, but was simply the largest pressure studied. Further application of this 
method only requires a tablet to be compressed to a pressure large enough to contain the 
pressure range of interest. Lycatab® PGS (Figure A.7) provides the best illustration for 
how this data correction is performed because of the relatively large contributions that 
elastic and viscoelastic deformation make to its behavior. The out-of-die solid fraction 
curve has been included for reference.  
 
 
Figure A. 7. In-die (―), elasticity corrected (•••), viscoelasticity corrected (•••), and out-
of-die solid fraction (□) versus pressure profiles for Lycatab® PGS compacted at 0.04 
mm/s 
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 Prediction accuracy of 𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 was assessed by comparing its value, at each of 
the seven pressures used to obtain the out-of-die compressibility profile, to the solid 
fraction values determined after complete elastic and viscoelastic recovery. These 
differences for Lycatab® PGS are presented in Figure A.8. 
 
 
Figure A. 8. Predicted (𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑) versus reference (Out-of-die SF) solid fraction values 
for Lycatab® PGS. 
 
 The difference in solid fraction at any pressure did not exceed 0.03. No difference 
was observed for tablets compressed to 264 MPa because this pressure was the reference 
pressure for determining ∆𝑆𝐹𝑓𝑖𝑛𝑎𝑙. This small difference suggests that the applied 
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examined. The out-of-die data are indistinguishable from the 𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 data in these 
plots. Next, corrected solid fraction data are converted to porosity using Eq. (7) and the 
natural logarithm transformed data are plotted as a function of pressure. Heckel plots for 
Lycatab® PGS are in Figure A.9.  
 
 
Figure A. 9. In-die (―), elasticity corrected (•••), viscoelasticity corrected (•••), and out-
of-die (□) Heckel plots for Lycatab® PGS compacted at 0.04 mm/s 
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(i.e. 𝑆𝐹𝑐/𝑑, 𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑, and out-of-die). Table A.1, on the following page, provides a 
summary of the Heckel analysis results for each Lycatab® PGS curve. 
 
Table A. 1 Calculated yield pressure values using Heckel analysis 
Material 
Uncorrected 
In-die Py
a 
(MPa) 
𝑆𝐹𝑐/𝑑 Py
a 
(MPa) 
𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 
Py
a (MPa) 
Out-of-die 
Py
a (MPa) 
 
Pre-gelatinized maize 
starch (Lycatab® PGS) 
 
55 (5) 
 
88 (10) 
 
134 (13) 
 
133 (14) 
 
aPy represents the average of the  reciprocal slope obtained from three replicate tablets 
compressed to 264 MPa 
 
 The error reported for apparent yield pressure reflects the standard deviation of 
three replicate tablets. The predicted apparent yield pressure did not deviate significantly 
from measured values. Out-of-die Heckel slope values, 𝑘, can be calculated by taking the 
inverse of yield pressure, 𝑃𝑦, using Eq. (27): 
 
 𝑘 =
1
𝑃𝑦
 (27) 
 
 For the data presented in Table A.1, the estimated out-of-die Heckel slope value 
using 𝑆𝐹𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 is 0.00746 compared to 0.00751 for the measured out-of-die data. The 
applicability of this method to generate out-of-die compressibility curves that can be fit to 
the Heckel model with precision and accuracy is significant because this is one of the 
most commonly used pieces of data by formulation scientists to guide tablet 
development. Not only is this method computationally simple, but it is also material-
 167 
sparing requiring as little as one tablet worth of material. Characterization of powder 
compressibility using this simple approach can improve productivity and streamline 
tablet development studies; allowing more information to be obtained from fewer 
experiments. The proposed method offers the ability to assess plasticity, using the Out-of-
Die Heckel Slope, quickly and independently. In cases where only small amounts of raw 
material are available or where a large number of different powders are to be studied, this 
method allows a detailed understanding of material deformation to be developed in a 
straightforward and reproducible manner.   
  
 
